SEARCH
Search Details
KOUNO KeijiGraduate School of Medicine / Faculty of Medical SciencesAssistant Professor
Research activity information
■ Award■ Paper
- INTRODUCTION: Several calcimimetics, other than cinacalcet, are commercially available; however, their effects on calcium and phosphate levels have not yet been fully studied. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate the impact of calcimimetics on the management of serum calcium and phosphate levels in patients with secondary hyperparathyroidism undergoing dialysis. METHODS: A systematic literature search through October 2023 and a meta-analysis were conducted on the effects of upacicalcet, etelcalcetide, evocalcet, and cinacalcet on serum calcium and phosphate levels in patients with secondary hyperparathyroidism undergoing dialysis; we searched PubMed, Ovid MEDLINE, and the Cochrane Central Register of Controlled Trials, and 21 studies comprising 6371 patients undergoing dialysis were included. RESULTS: Participants treated with calcimimetics had lower serum calcium and phosphate levels than placebo. CONCLUSION: Calcimimetics significantly reduced serum calcium and phosphate levels compared to placebo in patients with secondary hyperparathyroidism undergoing dialysis, independent of therapeutic strategy or concomitant vitamin D treatment.Aug. 2024, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 28(4) (4), 557 - 571, English, International magazineScientific journal
- (一社)日本移植学会, Nov. 2023, 移植, 58(2) (2), 172 - 172, Japanese
- (一社)日本アフェレシス学会, Oct. 2023, 日本アフェレシス学会雑誌, 42(Suppl.) (Suppl.), 138 - 138, Japanese
- (一社)日本アフェレシス学会, Oct. 2023, 日本アフェレシス学会雑誌, 42(Suppl.) (Suppl.), 142 - 142, Japanese
- (一社)日本腎臓学会, Sep. 2023, 日本腎臓学会誌, 65(6-W) (6-W), 771 - 771, JapaneseCOVID-19感染を契機にネフローゼ症候群を発症し,膜性増殖性糸球体腎炎(MGPN)と診断された1例
- (一社)日本腎臓学会, Sep. 2023, 日本腎臓学会誌, 65(6-W) (6-W), 804 - 804, Japanese詳細な遺伝子解析により診断に至った常染色体優性尿細管間質性腎疾患(ADTKD)の1例
- (株)東京医学社, Sep. 2023, 腎と透析, 95(3) (3), 411 - 417, Japanese
- (一社)日本腎臓学会, Sep. 2023, 日本腎臓学会誌, 65(6-W) (6-W), 771 - 771, JapaneseCOVID-19感染を契機にネフローゼ症候群を発症し,膜性増殖性糸球体腎炎(MGPN)と診断された1例
- BACKGROUND: Fabry disease (FD) is an inherited disorder that causes organ dysfunction. However, only a few studies have reported on bone mineral density (BMD) in FD patients, and the relationship between BMD and clinical factors such as globotriaosylsphingosine (lyso-Gb3) remains unclear. Therefore, the current study sought to investigate BMD in FD patients, the relationship between BMD and lyso-Gb3, and the effects of enzyme replacement therapy (ERT) on changes in BMD and lyso-Gb3. METHODS: This single-center, observational study included 15 patients who visited our facility for FD between January 2008 and June 2021. We assessed BMD and clinical characteristics in study patients, including plasma lyso-Gb3 levels, and examined the relationship between BMD and plasma lyso-Gb3 levels, and changes in BMD after starting ERT. RESULTS: Male patients' BMD had reduced, whereas female patients' BMD was preserved. Male patients had significantly higher plasma lyso-Gb3 levels than female patients. Moreover, plasma lyso-Gb3 levels were found to be significantly related to the lumbar spine and femoral BMD. These were strongly linked with plasma lyso-Gb3 levels in male patients, whereas no strong link was observed in female patients. Furthermore, BMD significantly increased only in male patients although plasma lyso-Gb3 levels significantly decreased by ERT in all patients. CONCLUSION: BMD decreased possibly due to Gb3 accumulation, and ERT could increase BMD in male FD patients.Aug. 2023, Molecular genetics and metabolism, 139(4) (4), 107634 - 107634, English, International magazineScientific journal
- BACKGROUND: Astragalus root is a commonly used herb in traditional Chinese medicine. Although renoprotective effects have been reported in some clinical and experimental studies, the details remain unknown. METHODS: We used 5/6 nephrectomized rats as chronic kidney disease (CKD) models. At 10 weeks, they were divided into four groups, namely, CKD, low-dose astragalus (AR400), high-dose astragalus (AR800), and sham groups. At 14 weeks, they were sacrificed for the evaluation of blood, urine, mRNA expression in the kidney, and renal histopathology. RESULTS: Kidney dysfunction was significantly improved following astragalus administration (creatinine clearance: sham group; 3.8 ± 0.3 mL/min, CKD group; 1.5 ± 0.1 mL/min, AR400 group; 2.5 ± 0.3 mL/min, AR800 group; 2.7 ± 0.1 mL/min). Blood pressure, urinary albumin, and urinary NGAL levels were significantly lower in the astragalus-treated groups than those in the CKD group. Excretion of urinary 8-OHdG, an oxidative stress marker, and intrarenal oxidative stress were lower in the astragalus-treated groups than those in the CKD group. Furthermore, the mRNA expression of NADPH p22 phox, NADPH p47 phox, Nox4, renin, angiotensin II type 1 receptor, and angiotensinogen in the kidney was lower in the astragalus-treated groups compared with the CKD group. CONCLUSION: This study suggests that astragalus root slowed CKD progression, possibly through the suppression of oxidative stress and the renin-angiotensin system.Jul. 2023, Clinical and experimental nephrology, 27(7) (7), 593 - 602, English, Domestic magazineScientific journal
- (一社)日本腎臓学会, May 2023, 日本腎臓学会誌, 65(3) (3), 192 - 192, Japaneseここが変わった!CKD診療ガイドライン2023 (第2章)高血圧・CVD
- AIMS: Serum phosphate control is crucial for the progression of vascular and valvular calcifications. Strict phosphate control is recently suggested; however, there is a lack of convincing evidence. Therefore, we explored the effects of strict phosphate control on vascular and valvular calcifications in incident patients undergoing hemodialysis. METHODS: A total of 64 patients undergoing hemodialysis from our previous randomized controlled trial were included in this study. Coronary artery calcification score (CACS) and cardiac valvular calcification score (CVCS) were evaluated using computed tomography and ultrasound cardiography at baseline and 18 months after the initiation of hemodialysis. The absolute changes in CACS (ΔCACS) and CVCS (ΔCVCS) and the percent change in CACS (%ΔCACS) and CVCS (%ΔCVCS) were calculated. Serum phosphate level was measured at 6, 12, and 18 months after the initiation of hemodialysis. Moreover, phosphate control status was evaluated using the area under the curve (AUC) by the amount of time spent with a serum phosphate level of ≥ 4.5 mg/dL and the extent to which this threshold exceeded over the observation period. RESULTS: ΔCACS, %ΔCACS, ΔCVCS, and %ΔCVCS were significantly lower in the low AUC group than in the high AUC group. ΔCACS and %ΔCACS were also significantly lower. ΔCVCS and %ΔCVCS tended to be lower in patients whose serum phosphate level never exceeded 4.5 mg/dL than in those whose serum phosphate level continuously exceeded 4.5 mg/dL. AUC significantly correlated with ΔCACS and ΔCVCS. CONCLUSION: Consistently strict phosphate control may slow the progression of coronary and valvular calcifications in incident patients undergoing hemodialysis.Mar. 2023, Journal of atherosclerosis and thrombosis, English, Domestic magazineScientific journal
- 2023, Clinical and Experimental NephrologyScientific journal
- 2023, Frontiers in Endocrinology, 14Scientific journal
- (一社)日本腎臓学会, Oct. 2022, 日本腎臓学会誌, 64(6-W) (6-W), 716 - 716, Japanese糸球体優位にM蛋白を貪食した組織球を認めたリンパ形質細胞性リンパ腫によるcrystal-storing histiocytosisの1症例
- (一社)日本腎臓学会, Oct. 2022, 日本腎臓学会誌, 64(6-W) (6-W), 738 - 738, Japanese質量分析にてCryofibrinogen関連糸球体腎炎と診断し自然寛解した1例
- BACKGROUND: Steroid pulse (SP) therapy is one of the immunosuppressive therapies for immunoglobulin A nephropathy (IgAN). Although there are various protocols of SP therapy in IgAN, the intermittent SP (ISP) and consecutive SP (CSP) protocols are prevalently performed in clinical settings. However, there is a lack of evidence of comparisons of the effects on IgAN between these two protocols. METHODS: A total of 189 patients with IgAN who had received SP therapy were included in this study. They were divided into two groups according to the SP protocols into the intermittent SP (ISP) or consecutive SP (CSP) group as follows: ISP; three-times SP therapy in alternate months, CSP; three-times SP therapy in three consecutive weeks. Kidney function, remission of urinary findings, and side effects of SP therapy were compared between the two groups. The observational period was 12 months after the initiation of SP therapy. RESULTS: There was no significant difference in kidney function between the two groups during the observational period. The remission rate of proteinuria and hematuria at 12 months also did not significantly differ between the two groups. Furthermore, even after the adjustment of clinical characteristics using propensity score matching, the remission rate of proteinuria and hematuria at 12 months was similar between the two groups. At 2 months, the remission rate of proteinuria was significantly higher in the CSP group than in the ISP group. There were no critical side effects in both groups. CONCLUSION: The effects of SP therapy on IgAN were similar between the ISP and CSP group at 12 months although CSP therapy could remit proteinuria faster than ISP therapy.Apr. 2022, BMC nephrology, 23(1) (1), 153 - 153, English, International magazineScientific journal
- BACKGROUND: Nephrotic syndrome (NS) results in massive proteinuria and hypoalbuminemia, which are responsible for a compensatory increase in protein synthesis in the liver. Serum cholinesterase (ChE) also increases in NS. However, its clinical value is not fully elucidated. METHODS: In this study, 184 patients with NS who underwent kidney biopsy were included. The patients were divided into two groups according to serum ChE levels, as follows: hypercholinesterasemia (HC) and non-hypercholinesterasemia (NHC) groups. The clinical factors were compared between the two groups. RESULTS: The HC group had significantly more severe proteinuria and higher prevalence of high selective proteinuria than the NHC group. Furthermore, the prevalence of minimal change nephrotic syndrome (MCNS) was significantly higher in the HC group than that in the NHC group. Multivariate analysis revealed that the severity of proteinuria and MCNS were significantly associated with HC. CONCLUSION: In this study, HC in NS was associated with the severity of proteinuria and MCNS, and could help clinicians predict the histological diagnosis of NS.Apr. 2022, BMC nephrology, 23(1) (1), 128 - 128, English, International magazineScientific journal
- Serum fibroblast growth factor 23 (FGF23) levels and the renin-angiotensin-aldosterone system (RAAS) are elevated in chronic kidney disease (CKD) patients, and their association with left ventricular hypertrophy (LVH) has been reported. However, whether the FGF23 elevation is the cause or result of LVH remains unclear. At 10 weeks, male C57BL/6J mice were divided into 4 groups: sham, CKD (5/6 nephrectomy), LVH (transaortic constriction), and CKD/LVH group. At 16 weeks, the mice were euthanized, and blood and urine, cardiac expressions of FGF23 and RAAS-related factors, and cardiac histological analyses were performed. Heart weight, serum FGF23 levels, and cardiac expression of FGF23 and RAAS-related factors, except for angiotensin-converting enzyme 2, were more increased in the CKD/LVH group compared to the other groups. A significant correlation between LVH and cardiac expressions of FGF23 and RAAS-related factors was observed. Furthermore, there was a significantly close correlation of the cardiac expression of FGF23 with LVH and RAAS-related factors. The coexisting CKD and LVH increased serum and cardiac FGF23 and RAAS-related factors, and there was a significant correlation between them. A close correlation of cardiac, but not serum FGF23, with LVH and RAAS suggests that local FGF23 levels may be associated with LVH and RAAS activation.Feb. 2022, Journal of the Endocrine Society, 6(2) (2), bvab187, English, International magazineScientific journal
- AIM: Acute kidney injury (AKI) is an important clinical issue in the diagnosis and treatment of cardiovascular diseases. The association between pretreatment by statins and the occurrence of AKI in patients with peripheral arterial diseases (PAD) remains unclear. Therefore, we examined the association between statin therapy and the occurrence of AKI in patients with PAD. METHODS: We retrospectively analyzed data from the endovascular treatment (EVT) database in our hospital. A total of 295 patients who underwent angiography and/or intervention for PAD between October 2011 and March 2016 were enrolled and divided into two groups: those without statins (control group; N=157) and those with statins (statin group; N=138) for at least 1 month before admission. We examined the occurrence of AKI and its related factors in these patients. RESULTS: The serum creatinine levels, dose of contrast medium, use of a renin-angiotensin system inhibitor, smoking habit, and blood pressure were similar in both groups. The statin group had more diabetes patients, had patients who were significantly younger, had patients with a higher body mass index (BMI), and had patients with lower low-density lipoprotein cholesterol than the control group. With regard to the occurrence of AKI, there was a significantly lower incidence in the statin group compared with the control group (5% vs. 16%, p<0.05). The result of the multivariate analysis indicated that statin therapy was significantly correlated with lower occurrence rates of AKI (p<0.05). CONCLUSIONS: Our study suggests that statin therapy might prevent the occurrence of AKI after angiography and/or intervention for PAD.Jan. 2022, Journal of atherosclerosis and thrombosis, English, Domestic magazineScientific journal
- 2022, Therapeutic Apheresis and DialysisScientific journal
- (一社)日本透析医学会, Nov. 2021, 日本透析医学会雑誌, 54(11) (11), 597 - 602, Japanese
- (株)日本メディカルセンター, Jun. 2021, 臨床透析, 37(6) (6), 587 - 593, Japanese
- (一社)日本透析医学会, May 2021, 日本透析医学会雑誌, 54(Suppl.1) (Suppl.1), 339 - 339, Japanese腎移植患者における副甲状腺摘除術によるカルシニューリン阻害薬血中濃度の変化
- INTRODUCTION: Very few studies have been performed to evaluate both the severity and site of aortic calcification (AC) in both end-stage kidney disease (ESKD) and diabetes mellitus (DM). The purpose of our study was to examine the utility of a newly developed three-dimensional (3D) visualization and quantification method compared with other methods to evaluate vascular calcification in ESKD patients with and without DM. MATERIALS AND METHODS: Fifty patients with ESKD before initiating hemodialysis at our hospital were included in the present study. They were divided into the two groups, depending on the presence or absence of DM: Control group (n = 31) and DM group (n = 19). The volume and site of AC were evaluated via computed tomography (CT) scan using a 3D visualization and quantification method. RESULTS: Total calcification volume was significantly greater in the DM group than in the Control group. Calcification volume in the descending and abdominal aortas was greater in the DM group compared to the Control group. There were no significant differences in calcification volume in the aortic root, ascending aorta, and aortic arch. Calcification volume of the whole aorta, the descending aorta, and the abdominal aorta were each significantly correlated with age, diastolic blood pressure and pulse pressure. CONCLUSION: This study using a 3D visualization and quantification method demonstrated that AC was more severe and occurred more frequently in the abdominal aorta in ESKD patients with DM compared to those without DM. This method would enable us to precisely evaluate the volume and distribution of AC.May 2021, Journal of bone and mineral metabolism, 39(3) (3), 439 - 445, English, Domestic magazineScientific journal
- (一社)日本血液浄化技術学会, Mar. 2021, 日本血液浄化技術学会会誌, 29(Suppl.) (Suppl.), 112 - 112, Japanese各治療法におけるアフェレシスの役割と施行条件 新鮮凍結血漿とアルブミン溶液を併用した単純血漿交換療法について
- (一社)日本血液浄化技術学会, Mar. 2021, 日本血液浄化技術学会会誌, 29(Suppl.) (Suppl.), 152 - 152, Japanese当院における遠心分離血漿交換療法の経験と膜分離血漿交換との比較
- Background: Within the class of tyrosine kinase inhibitors (TKIs), which are used for the treatment of numerous advanced cancers, lenvatinib is associated with a higher prevalence of hypertension (HT) compared with other TKIs. In this study, we investigated the effect of lenvatinib on blood pressure (BP) and associated factors. Methods: This single-centre, retrospective observational study included 25 consecutive patients treated with lenvatinib for unresectable hepatocellular carcinoma from April 2018 to December 2018 at the study institution. We assessed changes in BP using ambulatory BP monitoring, urinary sodium excretion, kidney function, use of antihypertensive agents and diuretics, and fluid retention following treatment initiation with lenvatinib. Results: At 1 week after treatment initiation, the mean BP and the percentage of patients with riser pattern significantly increased compared with those at the baseline. Although there were no significant changes at 1 week, urinary sodium excretion (153.4 ± 51.7 and 112.5 ± 65.0 mEq/day at 1 and 3 weeks, respectively, P < 0.05) and estimated glomerular filtration rate significantly decreased and the number of patients with fluid retention increased at 3 weeks. Furthermore, patients with fluid retention had significantly higher BP or required more intensive BP treatment compared with those without fluid retention. Conclusions: Lenvatinib might lead to HT without fluid retention soon after the initiation of treatment, subsequently leading to a reduction in urinary sodium excretion, thereby contributing to a rise in BP by fluid retention.Jan. 2021, Clinical kidney journal, 14(1) (1), 325 - 331, English, International magazineScientific journal
- Vascular calcification (VC) is a common complication in patients with chronic kidney disease (CKD). Particularly, CKD patients with diabetes mellitus (DM) develop severe VC. Specific mechanisms of VC remain unclear; this study aimed to investigate them in the context of coexisting CKD and DM, mainly regarding oxidative stress. Sprague Dawley rats were randomly divided into six groups as follows: control rats (Control), 5/6 nephrectomized rats (CKD), streptozotocin-injected rats (DM), 5/6 nephrectomized and streptozotocin-injected rats (CKD + DM), CKD + DM rats treated with insulin (CKD + DM + INS), and CKD + DM rats treated with antioxidant apocynin (CKD + DM + APO). At 18 weeks old, the rats were sacrificed for analysis. Compared to the control, DM and CKD groups, calcification of aortas significantly increased in the CKD + DM group. Oxidative stress and osteoblast differentiation-related markers considerably increased in the CKD + DM group compared with the other groups. Moreover, apocynin considerably reduced oxidative stress, osteoblast differentiation-related markers, and aortic calcification despite high blood glucose levels. Our data indicate that coexisting CKD and DM hasten VC primarily through an increase in oxidative stress; anti-oxidative therapy may prevent the VC progression.Nov. 2020, Scientific reports, 10(1) (1), 20708 - 20708, English, International magazineScientific journal
- (一社)日本アフェレシス学会, Oct. 2020, 日本アフェレシス学会雑誌, 39(Suppl.) (Suppl.), 138 - 138, Japanese血漿分離器の副作用が疑われる症例において遠心分離法で治療継続できた一例
- (一社)日本透析医学会, Oct. 2020, 日本透析医学会雑誌, 53(Suppl.1) (Suppl.1), 366 - 366, Japanese腎機能の低下に伴うwPTH/iPTH比の変化と臨床的意義
- (一社)日本透析医学会, Oct. 2020, 日本透析医学会雑誌, 53(Suppl.1) (Suppl.1), 415 - 415, Japanese淡路島における男性透析患者のファブリー病スクリーニング
- (一社)日本透析医学会, Oct. 2020, 日本透析医学会雑誌, 53(Suppl.1) (Suppl.1), 439 - 439, Japaneseアクションカードを用いた災害訓練導入後のスタッフの意識調査
- INTRODUCTION: Hyperparathyroidism (HPT) is associated with mortality and cardiovascular disease (CVD) in dialysis patients. However, its mechanism is still unclear. It is suspected that parathyroid hormone (PTH) is associated with the renin-angiotensin-aldosterone system (RAAS) as a possible mechanism. Thus, we examined their hormonal interaction in hemodialysis patients with secondary HPT. MATERIALS AND METHODS: Seventeen hemodialysis patients with HPT were included. All patients underwent total parathyroidectomy (PTx). Serum intact PTH (iPTH), calcium and phosphate levels, plasma renin activity (PRA), and plasma aldosterone levels (ALD) were measured pre- and post-PTx. RESULTS: Pre-serum iPTH tended to be correlated with pre-PRA and were significantly correlated with pre-ALD (pre-PRA: r = 0.44, p = 0.07, pre-ALD: r = 0.49, p < 0.05). With the reduction in serum iPTH after PTx, PRA and ALD significantly decreased after PTx. Additionally, the change in serum iPTH tended to be correlated with the changes in PRA and ALD (PRA; r = 0.46, p = 0.05, ALD; r = 0.45, p = 0.06). CONCLUSION: Our results suggest that PTH could be interrelated with RAAS in hemodialysis patients with secondary HPT.Sep. 2020, Journal of bone and mineral metabolism, 39(2) (2), 230 - 236, English, Domestic magazineScientific journal
- BACKGROUND: Although a previous study has reported the relationship between intact parathyroid hormone (iPTH) and whole parathyroid hormone (wPTH) levels in patients undergoing dialysis, the w/i PTH ratio (whole/intact PTH ratio) among predialysis chronic kidney disease (CKD) patients remains unclear. The present study therefore aimed to examine the relationship between w/i PTH ratio and kidney function and determine other factors affecting the w/i PTH ratio. METHODS: An observational study including 773 predialysis CKD patients was conducted. The correlation between w/i PTH ratio and kidney function, as well as clinical factors at different CKD stages, were assessed using univariate and multivariate analyses. In addition, the relationship between w/i PTH ratio and composite renal outcome [kidney transplantation, dialysis, and 30% decline in estimated glomerular filtration rate (eGFR)] was examined. RESULTS: The w/i PTH ratio decreased as the CKD stage progressed. Patients in each CKD stage (1/2, 3, 4, and 5) had a w/i PTH ratio of 0.85, 0.81, 0.78, and 0.59, respectively. The inflection point in the correlation lines between eGFR and w/i PTH ratio was 24.1 mL/min/1.73 m2. In multivariate analysis, the w/i PTH ratio was significantly correlated with serum calcium levels only in the CKD5 group and with eGFR in the CKD3, CKD4 and CKD5 group. Furthermore, w/i PTH ratio, eGFR, serum phosphate levels, and urinary protein/creatinine ratio were determined to be significant independent predictors for composite renal outcome. CONCLUSIONS: Our study demonstrated that changes in the w/i PTH ratio were associated with kidney function, abnormal mineral metabolism, and renal outcome.Aug. 2020, Journal of nephrology, 33(4) (4), 795 - 802, English, International magazineScientific journal
- Aug. 2020, Journal of nephrology, 33(4) (4), 657 - 659, English, International magazineScientific journal
- (一社)日本腎臓学会, Jul. 2020, 日本腎臓学会誌, 62(4) (4), 264 - 264, JapaneseIgA腎症に対するステロイドパルス療法のプロトコールによる治療効果の比較
- (一社)日本腎臓学会, Jul. 2020, 日本腎臓学会誌, 62(4) (4), 269 - 269, Japaneseループス腎炎患者における腎病型と心筋障害との関連
- (一社)日本腎臓学会, Jul. 2020, 日本腎臓学会誌, 62(4) (4), 333 - 333, Japanese慢性腎臓病患者における心電図・心エコー異常の有無による背景と虚血スクリーニング陽性率の違い
- (一社)日本腎臓学会, Jul. 2020, 日本腎臓学会誌, 62(4) (4), 335 - 335, Japanese心肥大+慢性腎臓病モデルマウスにおけるFGF23、RAS関連因子についての検討
- BACKGROUND Microscopic tumor foci have been detected incidentally on renal biopsy, including renal cell carcinoma and renomedullary interstitial cell tumor (medullary fibroma). A report is presented of a case of an incidental finding of microscopic renal angiomyolipoma that was diagnosed and completely excised on core needle biopsy. CASE REPORT A 44-year-old woman was referred to our hospital for evaluation of persistent mild proteinuria. Three years previously, she was diagnosed with Cushing's syndrome associated with a right adrenal cortical adenoma, which was successfully treated with unilateral adrenalectomy. At the time of surgery, abdominal computed tomography (CT) showed no renal lesions. During the present admission, a renal biopsy was performed that showed minimal changes in the renal glomeruli and interstitium. Immunofluorescence showed weakly positive staining for IgM in the glomeruli and no dense deposits. A microscopic focus of a predominantly spindle-cell tumor was found in the corticomedullary region. Immunohistochemistry showed positive immunostaining for HMB-45, Melan-A, and alpha-smooth muscle actin (ASMA), which supported a diagnosis of angiomyolipoma. Abdominal ultrasound at one-year follow-up showed no evidence of residual renal tumor. CONCLUSIONS To our knowledge, this is the first reported case of a completely excised incidental microscopic renal angiomyolipoma. This case demonstrated that even when imaging findings are normal, renal biopsy may detect microscopic foci of primary renal tumors.Mar. 2020, The American journal of case reports, 21, e921353, English, International magazine
- We encountered a pregnant hemodialysis patient with severe hyperparathyroidism (HPT). Although her disease was considered to be refractory to medical treatment, the serum intact parathyroid hormone (PTH) level remarkably improved without manifestation of hypercalcemia through only strict serum phosphorus control, mainly via intensification of dialysis. The very strong correlation between the serum phosphorus level and serum intact PTH level suggested the possibility of secondary HPT. She ultimately gave birth to a healthy baby. The clinical course of the patient's HPT and the growth of the child have been good for more than six years.Mar. 2020, Internal medicine (Tokyo, Japan), 59(5) (5), 689 - 694, English, Domestic magazineScientific journal
- BACKGROUND: Although mineral metabolism disorder influences cardiac valvular calcification (CVC), few previous studies have examined the effects of non-calcium-containing and calcium-containing phosphate binders on CVC in maintenance hemodialysis patients. The aim of the present study was to compare the effects of lanthanum carbonate (LC) with calcium carbonate (CC) on the progression of CVC in patients who initiated maintenance hemodialysis and to investigate clinical factors related to CVC. METHODS: The current study included 50 subjects (mean age 65 years, 72% males) from our previous randomized controlled trial (LC group, N = 24; CC group, N = 26). CVC was evaluated as CVC score (CVCS) using echocardiography at baseline and 18 months after initiation of hemodialysis. We compared CVCS and the changes between the two groups. We also analyzed the associations between CVCS and any other clinical factors including arterial plaque score (PS) and serum phosphorus levels. RESULTS: Baseline characteristics of study participants including CVCS were almost comparable between the two groups. At 18 months, there were no significant differences in mineral metabolic markers or CVCS between the two groups, and CVCS were significantly correlated with PS (r = 0.39, p < 0.01). Furthermore, changes in CVCS were significantly correlated with average phosphorus levels (r = 0.36, p < 0.05), which were significantly higher in high serum phosphorus and high PS group compared to low serum phosphorus and low PS group (p < 0.05). CONCLUSIONS: In the present study, there were no significant differences between LC and CC with regard to progression of CVC. However, serum phosphorus levels and arterial plaque seem to be important for the progression and formation of CVC in hemodialysis patients.Jan. 2020, BMC cardiovascular disorders, 20(1) (1), 39 - 39, English, International magazineScientific journal
- Cardiac abnormalities, including left ventricular hypertrophy and systolic dysfunction, are frequently observed among patients with CKD, including kidney transplant recipients; they are closely linked to cardiovascular disease and mortality. Although several studies have been performed for elucidating changes and mechanisms of cardiac abnormalities after kidney transplantation, details remain unclear. This study included 43 consecutive patients who underwent HD and received kidney transplantation between 2008 and 2012 at our institution. All subjects underwent echocardiography before and 1 year after kidney transplantation. One year after kidney transplantation, left ventricular mass index, cardiac chamber sizes, BP, and the number of antihypertensive agents were reduced. Although the percentage of patients with concentric hypertrophy did not change, the percentage of those with eccentric hypertrophy significantly decreased after kidney transplantation. Volume reduction due to the recovery of kidney function may be primarily attributed to the improvement of cardiac abnormalities, including left ventricular hypertrophy.Dec. 2019, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 23(6) (6), 529 - 533, English, International magazine[Refereed]
- (一社)日本内科学会, Sep. 2019, 日本内科学会雑誌, 108(9) (9), 1968 - 1973, Japanese
- (一社)日本腎臓学会, Aug. 2019, 日本腎臓学会誌, 61(6) (6), 883 - 883, JapaneseIV型コラーゲンα5鎖染色正常巣状分節性糸球体硬化症で遺伝子診断にてAlport症候群と診断した1例
- (一社)日本腎臓学会, Aug. 2019, 日本腎臓学会誌, 61(6) (6), 886 - 886, Japanese腎細胞癌に対してニボルマブ投与中にネフローゼ症候群を来した一例
- (一社)日本腎臓学会, Aug. 2019, 日本腎臓学会誌, 61(6) (6), 909 - 909, Japanese両心補助人工心臓を要する拡張型心筋症にて心臓移植待機中に腎機能障害を認めた1例
- BioMed Central Ltd., Jul. 2019, Renal Replacement Therapy, 5(1) (1), EnglishScientific journal
- Patients with chronic kidney disease (CKD) commonly experience cardiovascular disease (CVD), and a major cause of death in these patients is CVD. Therefore, the prevention of CVD progression is very crucial in patients with CKD. Recently, this relationship between CKD and CVD has increasingly been examined, and a concept termed "cardiorenal syndrome" has been advocated. Coronary artery disease (CAD) and myocardial injury are crucial factors that contribute to the occurrence of CVD. The initial step CAD is endothelial dysfunction that can be detected as a decrease in the coronary flow reserve (CFR). The previous studies have reported that decreased CFR is significantly correlated to coronary events and mortality. Furthermore, CFR reduces with a decline in the kidney function. Another important presentation of CAD is coronary artery calcification. Vascular calcification is a crucial pathophysiological state, particularly in patients with CKD, and it affects the stability of coronary atherosclerotic plaque. In CKD, not only the traditional risk factors but also CKD-related non-traditional risk factors play key roles in CVD progression. Therefore, the mechanisms responsible for CVD progression are very complex; however, their clarification is crucial to improve the prognosis in patients with CKD.Jun. 2019, Clinical and experimental nephrology, 23(6) (6), 725 - 732, English, Domestic magazine[Refereed]Scientific journal
- Jun. 2019, Journal of bone and mineral metabolism[Refereed]
- 日本下肢救済・足病学会, Jun. 2019, 日本下肢救済・足病学会誌, 11(2) (2), 143 - 143, Japanese兵庫県下での下肢末梢動脈疾患指導加算に関するアンケート調査
- (一社)日本透析医学会, May 2019, 日本透析医学会雑誌, 52(Suppl.1) (Suppl.1), 353 - 353, Japanese症例から末期腎臓病患者の大動脈弁狭窄症の治療戦略を考察する 経カテーテル大動脈弁留置術(TAVI)を施行した末期腎臓病患者の一例
- (一社)日本透析医学会, May 2019, 日本透析医学会雑誌, 52(Suppl.1) (Suppl.1), 439 - 439, Japanese腎機能の低下に伴うwPTH/iPTH比の変化についての検討
- (一社)日本透析医学会, May 2019, 日本透析医学会雑誌, 52(Suppl.1) (Suppl.1), 543 - 543, Japanese兵庫県下での下肢末梢動脈疾患指導加算に関するアンケート調査
- (一社)日本血液浄化技術学会, Apr. 2019, 日本血液浄化技術学会会誌, 27(Suppl.) (Suppl.), 180 - 180, Japanese
- A 77-year-old man was referred to our hospital with persistent proteinuria and progressive lower leg edema. Past history was unremarkable except for hypertension. Autoimmune diseases, infections, and malignancies were excluded based on clinical and laboratory test results. Renal biopsy specimens showed membranous nephropathy with segmental distribution of spikes and bubbling appearance. Double contour formation in glomerular tufts was also observed. There were no proliferative changes in the glomeruli. Interstitial fibrosis and tubular atrophy were moderate, and no interstitial inflammation was observed. Arteries showed moderate sclerotic changes with hyalinosis. Immunohistochemical analysis revealed no thrombospondin type 1 domain-containing 7A reactivity. Immunofluorescence staining showed segmental granular positivity of IgG on glomerular tufts and focal staining of IgG on the tubular basement membranes. IgG deposits (subclass distribution: IgG1, 2+; IgG2, -; IgG3, 1+; IgG4, 2+) and phospholipase A2 receptor type 1 (PLA2R1) immunoreactivity showed similar distributions in both glomeruli and renal tubular basement membranes. Electron microscopy revealed subendothelial edema in partially collapsed glomerulus. No subepithelial dense deposits were observed in the glomeruli under an electron microscope. This is the first documented case of membranous nephropathy (MN) with segmental distribution of PLA2R1 in the glomeruli and focal PLA2R1 positivity in renal tubular basement membranes. Our findings extend the pathological presentation of PLA2R1-associated MN. Future studies are required to examine the mechanistic insights of these atypical histopathological features. .Feb. 2019, Clinical nephrology, 91(2) (2), 114 - 119, English, International magazine[Refereed]Scientific journal
- Dec. 2018, Clin Exp Nephrol, 23(5) (5), 589 - 596, English[Refereed]Scientific journal
- (一社)日本透析医学会, Aug. 2018, 日本透析医学会雑誌, 51(8号) (8号), 517 - 523, Japanese[Refereed]Scientific journal
- May 2018, NEPHROLOGY DIALYSIS TRANSPLANTATION, 33THE SIGNIFICANT RELATIONSHIP BETWEEN INTRAVENTRICULAR SEPTUM THICKNESS (IVST) AND DECLINE OF EGFR IN AA AMYLOIDOSIS[Refereed]
- Springer New York LLC, Mar. 2018, Calcified Tissue International, 102(3) (3), 310 - 320, English[Refereed]Scientific journal
- Feb. 2018, Journal of Atherosclerosis and Thrombosis (Web), 25(2) (2), 170‐177(J‐STAGE), EnglishNewly Developed Rat Model of Chronic Kidney Disease-Mineral Bone Disorder[Refereed]Scientific journal
- Japan Atherosclerosis Society, 2018, Journal of Atherosclerosis and Thrombosis, 25(2) (2), 170 - 177, English[Refereed]Scientific journal
- Sep. 2017, HEART AND VESSELS, 32(9) (9), 1109 - 1116, English[Refereed]Scientific journal
- Aug. 2017, THERAPEUTIC APHERESIS AND DIALYSIS, 21(4) (4), 320 - 325, English[Refereed]Scientific journal
- Mar. 2017, JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 167, 55 - 60, English[Refereed]Scientific journal
- (一社)日本透析医学会, Feb. 2017, 日本透析医学会雑誌, 50(2号) (2号), 157 - 161, Japanese[Refereed]Scientific journal
- S. Karger AG, Jan. 2017, Case Reports in Nephrology and Dialysis, 7(1) (1), 26 - 33, English[Refereed]Scientific journal
- Oct. 2016, 臨床体液, 43, 9 - 13, Japanese著明な低Ca血症と低Mg血症を認め痙攣を来した常用飲酒者の1例[Refereed]Scientific journal
- (一社)日本移植学会, Oct. 2016, 移植, 51(4-5号) (4-5号), 411 - 415, Japanese[Refereed]Scientific journal
- Apr. 2016, BRITISH JOURNAL OF PHARMACOLOGY, 173(8) (8), 1302 - 1313, English[Refereed]Scientific journal
- 2016, CLINICAL AND EXPERIMENTAL HYPERTENSION, 38(5) (5), 476 - 481, English[Refereed]Scientific journal
- 2016, KIDNEY & BLOOD PRESSURE RESEARCH, 41(4) (4), 374 - 383, English[Refereed]Scientific journal
- S. Karger AG, 2016, Case Reports in Nephrology and Dialysis, 6(1) (1), 40 - 45, English[Refereed]Scientific journal
- Oxford University Press, 2016, Clinical Kidney Journal, 9(5) (5), 677 - 681, English[Refereed]Scientific journal
- Dec. 2015, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 19(6) (6), 1184 - 1188, English[Refereed]Scientific journal
- Dec. 2015, CARDIOVASCULAR DRUGS AND THERAPY, 29(6) (6), 499 - 507, English[Refereed]Scientific journal
- Sep. 2015, CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 42(9) (9), 972 - 978, English[Refereed]Scientific journal
- Blackwell Publishing, Sep. 2015, Clinical and Experimental Pharmacology and Physiology, 42(9) (9), 972 - 978, English[Refereed]Scientific journal
- May 2015, BONE, 74, 153 - 159, English[Refereed]Scientific journal
- Dec. 2014, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 18(6) (6), 925 - 931, English[Refereed]Scientific journal
- Apr. 2014, AMERICAN JOURNAL OF HYPERTENSION, 27(4) (4), 586 - 595, English[Refereed]Scientific journal
- Feb. 2014, Nephron Extra, 4(1) (1), 18 - 25, English[Refereed]Scientific journal
- Jun. 2013, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 17(3) (3), 365 - 371, English[Refereed]Scientific journal
- Mar. 2013, American Journal of Nephrology, 37(2) (2), 167 - 174, English[Refereed]Scientific journal
- Feb. 2013, THERAPEUTIC APHERESIS AND DIALYSIS, 17(1) (1), 24 - 29, English[Refereed]Scientific journal
- Dec. 2012, Clinical Kidney Journal, 5(6) (6), 512 - 518, English[Refereed]Scientific journal
- Aug. 2012, KIDNEY INTERNATIONAL, 82(3) (3), 344 - 351, English[Refereed]Scientific journal
- Feb. 2011, THERAPEUTIC APHERESIS AND DIALYSIS, 15(1) (1), 44 - 50, English[Refereed]Scientific journal
- 2011, AMERICAN JOURNAL OF NEPHROLOGY, 33(3) (3), 218 - 223, English[Refereed]Scientific journal
- 2011, AMERICAN JOURNAL OF NEPHROLOGY, 34(3) (3), 281 - 290, English[Refereed]Scientific journal
- Dec. 2010, Endocrine, 38(3) (3), 369 - 376, English[Refereed]Scientific journal
- Hamada Y, Kitazawa S, Kitazawa R, Kono K, Goto S, Komaba H, Fujii H, Yamamoto Y, Yamamoto H, Usami M, Fukagawa M, Endocrine, 2010, vol. 38, no. 3, pp. 369-376Dec. 2010, Endocrine, 38(3) (3), 369 - 376[Refereed]
- Oct. 2010, NDT Plus, 3(5) (5), 494 - 495, English[Refereed]Scientific journal
- 2010, AMERICAN JOURNAL OF NEPHROLOGY, 31(4) (4), 342 - 352, English[Refereed]Scientific journal
- 2009, AMERICAN JOURNAL OF NEPHROLOGY, 30(6) (6), 527 - 535, English[Refereed]Scientific journal
- (一社)日本腎臓学会, Aug. 2008, 日本腎臓学会誌, 50(6) (6), 716 - 716, Japanese急性心不全と腎機能障害を来したLeriche症候群の1例
- (一社)日本腎臓学会, Aug. 2008, 日本腎臓学会誌, 50(6) (6), 714 - 714, JapaneseWhole PTH/intact PTH逆転を呈する二次性副甲状腺機能亢進症の臨床的特徴
- 2021, 日本腎臓学会誌(Web), 63(6-W) (6-W)難治性重症ネフローゼ症候群に対し免疫抑制療法と血漿交換により完全寛解に至ったSLEの一例
- 2021, 日本腎臓学会誌(Web), 63(6-W) (6-W)Medullary angiitisと診断した腎膿瘍疑い症例
- 2021, 臨床透析, 37(6) (6)How could we reduce the incidence of atrial fibrillation in dialysis patients?
- 2020, 日本CKDーMBD研究会学術集会・総会プログラム・抄録集, 4th慢性腎臓病,糖尿病およびその合併が血管石灰化に及ぼす影響に関する検討
- (株)メジカルビュー社, Aug. 2019, Heart View, 23(8) (8), 769 - 773, Japanese【診療に活かす臨床検査活用術!知っていますか こんなこと、あんなこと】治す 循環器疾患における腎機能評価のポイント
- (一社)日本腎臓学会, May 2019, 日本腎臓学会誌, 61(3) (3), 334 - 334, Japaneseネフローゼ症候群におけるコレステロール、コリンエステラーゼの変化と臨床的特徴
- (一社)日本腎臓学会, May 2019, 日本腎臓学会誌, 61(3) (3), 371 - 371, Japaneseレンバチニブの血圧への影響とその臨床的特徴
- (一社)日本腎臓学会, May 2019, 日本腎臓学会誌, 61(3) (3), 422 - 422, Japanese腎移植患者と血液透析患者における腹部大動脈石灰化進展速度の比較
- (一社)日本透析医学会, May 2019, 日本透析医学会雑誌, 52(Suppl.1) (Suppl.1), 353 - 353, Japanese症例から末期腎臓病患者の大動脈弁狭窄症の治療戦略を考察する 経カテーテル大動脈弁留置術(TAVI)を施行した末期腎臓病患者の一例
- (一社)日本透析医学会, May 2019, 日本透析医学会雑誌, 52(Suppl.1) (Suppl.1), 439 - 439, Japanese腎機能の低下に伴うwPTH/iPTH比の変化についての検討
- (一社)日本透析医学会, May 2019, 日本透析医学会雑誌, 52(Suppl.1) (Suppl.1), 543 - 543, Japanese兵庫県下での下肢末梢動脈疾患指導加算に関するアンケート調査
- (一社)日本アフェレシス学会, Oct. 2018, 日本アフェレシス学会雑誌, 37(Suppl.) (Suppl.), 152 - 152, Japanese新鮮凍結血漿とアルブミン溶液併用による全血漿交換療法に関する検討
- (NPO)日本高血圧学会, Sep. 2018, 日本高血圧学会総会プログラム・抄録集, 41回, OC06 - 05, Japanese血液透析患者における二次性副甲状腺機能亢進症のレニン・アルドステロン系への影響
- (NPO)日本高血圧学会, Sep. 2018, 日本高血圧学会総会プログラム・抄録集, 41回, OC13 - 06, Japanese糖尿病合併末期腎不全患者における大動脈の血管石灰化部位に関する検討
- (NPO)日本高血圧学会, Sep. 2018, 日本高血圧学会総会プログラム・抄録集, 41回, OP01 - 02, Japanese総腸骨動脈狭窄症による急激な血圧上昇と腎機能低下を認めた腎移植患者の一例
- (株)じほう, Sep. 2018, 調剤と情報, 24(12号) (12号), 1712 - 1715, Japanese【処方解析に活かす心腎連関の考え方】 心腎保護を考慮した降圧薬の使い方 利尿薬、Ca拮抗薬の使い方Introduction commerce magazine
- (一社)日本腎臓学会, Aug. 2018, 日本腎臓学会誌, 60(6) (6), 722 - 722, Japanese自己免疫性膵炎治療中より腎機能低下を来し治療終了後に多臓器病変へと進展したIgG4関連疾患の1例
- (一社)日本腎臓学会, Aug. 2018, 日本腎臓学会誌, 60(6) (6), 731 - 731, JapaneseSAPHO症候群に腎アミロイドーシスを合併した1例
- (一社)日本腎臓学会, Aug. 2018, 日本腎臓学会誌, 60(6) (6), 735 - 735, Japanese非ファブリー病レシピエントにおけるファブリー病移植腎の経時的な病理学的変化
- (一社)日本透析医学会, May 2018, 日本透析医学会雑誌, 51(Suppl.1) (Suppl.1), 433 - 433, Japanese兵庫県下での透析患者に対する鉄含有リン吸着薬使用に関するアンケート調査
- (一社)日本透析医学会, May 2018, 日本透析医学会雑誌, 51(Suppl.1) (Suppl.1), 508 - 508, Japanese炭酸ランタンの血液透析患者骨代謝マーカーに与える影響
- (一社)日本透析医学会, May 2018, 日本透析医学会雑誌, 51(Suppl.1) (Suppl.1), 508 - 508, Japanese炭酸ランタンと炭酸カルシウムが透析導入後の弁石灰化に与える影響の比較
- (一社)日本透析医学会, May 2018, 日本透析医学会雑誌, 51(Suppl.1) (Suppl.1), 638 - 638, Japanese当院における血液透析患者での肺高血圧症に対する治療介入とその成果
- (一社)日本透析医学会, May 2018, 日本透析医学会雑誌, 51(Suppl.1) (Suppl.1), 729 - 729, Japanese二重濾過血漿交換療法とアルブミン置換血漿交換療法の除去率に関する検討
- (株)東京医学社, May 2018, 腎と透析, 84(増刊) (増刊), 446 - 448, Japanese【腎と透析ベッドサイド検査事典】 (第14章)腎移植患者の検査 内科的合併症の検査Introduction commerce magazine
- (一社)日本腎臓学会, Apr. 2018, 日本腎臓学会誌, 60(3) (3), 274 - 274, Japanese慢性腎臓病における心血管疾患
- (一社)日本腎臓学会, Apr. 2018, 日本腎臓学会誌, 60(3) (3), 448 - 448, Japanese腎移植種類による移植後骨ミネラル代謝の特徴
- (一社)日本腎臓学会, Apr. 2018, 日本腎臓学会誌, 60(3) (3), 461 - 461, Japanese糖尿病合併CKDモデルラットにおける血管石灰化の検討
- (株)日本メディカルセンター, Mar. 2018, 臨床透析, 34(3号) (3号), 295 - 300, Japanese【キュアとケアをつなぐナーシングスキル】 実践報告 移植後透析再導入患者に対するキュアとケア 「キュア」と「ケア」の立場からのチームアプローチIntroduction commerce magazine
- (株)東京医学社, Nov. 2017, 腎と透析, 83(別冊 腹膜透析2017) (別冊 腹膜透析2017), 79 - 80, Japaneseイコデキストリンによる腹膜透析患者の心血管イベント抑制効果
- (株)東京医学社, Nov. 2017, 腎と透析, 83(別冊 腹膜透析2017) (別冊 腹膜透析2017), 181 - 182, Japanese糖尿病合併腹膜透析患者における導入1年間の心臓超音波所見の変化
- 日本適応医学会, Nov. 2017, 適応医学, 21(1) (1), 9 - 9, Japanese心腎関連の病態と生体内での適応 慢性腎臓病からみた心腎連関
- (一社)日本腎臓学会, Sep. 2017, 日本腎臓学会誌, 59(6) (6), 710 - 710, JapaneseIgG4関連腎臓病の診断・治療後にIgG4上昇を認めない尿細管間質性腎炎を来した一例
- (一社)日本腎臓学会, Sep. 2017, 日本腎臓学会誌, 59(6) (6), 873 - 873, JapaneseWater-clear cell parathyroid adenomaにより症候性高カルシウム血症を来した1例
- (一社)日本透析医学会, May 2017, 日本透析医学会雑誌, 50(Suppl.1) (Suppl.1), 492 - 492, Japanese腎・血液浄化センターの医療安全への取り組み ヒューマンエラーに対するタイムアウトの導入
- (一社)日本透析医学会, May 2017, 日本透析医学会雑誌, 50(Suppl.1) (Suppl.1), 687 - 687, Japanese血液透析患者における新たな血管石灰化関連因子であるEXTL2に関する研究
- (一社)日本透析医学会, May 2017, 日本透析医学会雑誌, 50(Suppl.1) (Suppl.1), 809 - 809, Japaneseマクログロブリン血症に対し血漿交換療法を施行した2症例
- (株)日本医事新報社, May 2017, 日本医事新報, (4854号) (4854号), 41 - 47, Japanese【腎硬化症への対策】 腎硬化症への透析導入の判断と維持[Invited]Introduction other
- (一社)日本腎臓学会, Apr. 2017, 日本腎臓学会誌, 59(3) (3), 247 - 247, Japaneseネフローゼ症候群における血管内皮リパーゼに対するスタチンの影響
- (一社)日本腎臓学会, Apr. 2017, 日本腎臓学会誌, 59(3) (3), 307 - 307, Japanese腎移植患者における移植1年後の心臓パラメーターの変化
- (一社)日本腎臓学会, Apr. 2017, 日本腎臓学会誌, 59(3) (3), 367 - 367, Japanese腎臓病教育入院中のeGFRの低下と腎予後の検討
- (一社)日本循環器学会, Mar. 2017, 日本循環器学会学術集会抄録集, 81回, PJ - 596, English透析を開始した患者における骨塩密度と左室肥大との関連性(Relationship between Bone Mineral Density and Left Ventricular Hypertrophy in Incident Dialysis Patients)
- (株)最新医学社, Dec. 2016, 最新医学, 71(12号) (12号), 2434 - 2440, Japanese[Invited]Introduction scientific journal
- (一社)日本アフェレシス学会, Nov. 2016, 日本アフェレシス学会雑誌, 35(Suppl.) (Suppl.), 184 - 184, Japanese当院における体重30kg未満の小児ABO不適合腎移植前抗体除去療法
- (NPO)日本高血圧学会, Sep. 2016, 日本高血圧学会総会プログラム・抄録集, 39回, 332 - 332, Japanese高血圧モデルラットにおけるFGF23、Ca、Pの変化
- (NPO)日本高血圧学会, Sep. 2016, 日本高血圧学会総会プログラム・抄録集, 39回, 357 - 357, Japanese非顕性蛋白尿の糖尿病合併慢性腎臓病患者における血圧日内変動の特徴
- (一社)日本腎臓学会, Aug. 2016, 日本腎臓学会誌, 58(6) (6), 917 - 917, JapaneseZebra body様蓄積物を水晶体上皮細胞に認めたE66Q変異の1症例
- (一社)日本腎臓学会, Aug. 2016, 日本腎臓学会誌, 58(6) (6), 920 - 920, JapaneseFanconi症候群を合併したネフローゼ症候群の一例
- (一社)日本腎臓学会, Aug. 2016, 日本腎臓学会誌, 58(6) (6), 922 - 922, Japanese副甲状腺腺腫からの出血により深頸部縦隔血腫をきたした1例
- May 2016, NEPHROLOGY DIALYSIS TRANSPLANTATION, 31, 252 - 252, EnglishEFFECT OF LANTHANUM CARBONATE ON CORONARY ARTERY CALCIFICATION DURING THE EARLY PERIOD AFTER THE INITIATION OF HAEMODIALYSISSummary international conference
- May 2016, NEPHROLOGY DIALYSIS TRANSPLANTATION, 31, 1466 - 1466, EnglishSERUM FIBROBLAST GROWTH FACTOR 23 LEVELS IN PATIENTS WITH HYPOPHOSPHATEMIA DUE TO FANCONI SYNDROMESummary international conference
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 272 - 272, Japanese先行的腎移植は移植後早期に心肥大を改善させる
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 293 - 293, Japanese新規ビタミンD製剤VS-105とパリカルシトールのCKD-MBDに対する作用の比較
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 299 - 299, Japanese急性冠症候群患者における血清インドキシル硫酸濃度の変化
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 310 - 310, Japanese腎移植レシピエントの透析導入に関する検討
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 330 - 330, JapaneseFanconi症候群患者における血清FGF23値
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 349 - 349, Japanese非顕性蛋白尿を呈する糖尿病合併慢性腎臓病患者の臨床的特徴
- (一社)日本腎臓学会, May 2016, 日本腎臓学会誌, 58(3) (3), 370 - 370, JapaneseHenoch-Schoelein紫斑病における腎組織および臨床所見と皮膚組織所見に関する検討
- (一社)日本透析医学会, May 2016, 日本透析医学会雑誌, 49(Suppl.1) (Suppl.1), 442 - 442, Japanese肝硬変による難治性腹水合併腎不全患者において、腹腔静脈シャントが体液管理に有効であった一例
- (一社)日本透析医学会, May 2016, 日本透析医学会雑誌, 49(Suppl.1) (Suppl.1), 449 - 449, Japanese維持血液透析患者における大動脈弁狭窄症手術時の臨床的特徴
- (一社)日本内科学会, Feb. 2016, 日本内科学会雑誌, 105(Suppl.) (Suppl.), 218 - 218, Japaneseネフローゼ症候群の診断鑑別における尿比重の意義
- 2016, 日本臨床腎移植学会プログラム・抄録集, 49th神戸大学における先行的腎移植症例の検討
- (株)東京医学社, Jan. 2016, 腎と透析, 80(1号) (1号), 47 - 52, Japanese[Invited]Introduction scientific journal
- (有)科学評論社, Dec. 2015, 腎臓内科・泌尿器科, 2(6) (6), 539 - 546, Japanese【腎とミネラル代謝】腎移植患者におけるミネラル管理
- Nov. 2015, CIRCULATION, 132, EnglishAST-120 Prevents the Progression of Kidney Injury After Myocardial InfarctionSummary international conference
- (NPO)日本高血圧学会, Oct. 2015, 日本高血圧学会総会プログラム・抄録集, 38回, 383 - 383, Japanese慢性腎臓病における冠動脈石灰化と24時間自由行動下血圧の関係
- (NPO)日本高血圧学会, Oct. 2015, 日本高血圧学会総会プログラム・抄録集, 38回, 452 - 452, Japanese当科における線維筋性異形成による腎動脈狭窄症例の臨床的特徴
- (一社)日本腎臓学会, Aug. 2015, 日本腎臓学会誌, 57(6) (6), 1111 - 1111, Japaneseレシピエントの移植後腎生検で発見されたファブリー病腎移植ドナーの1症例
- (一社)日本腎臓学会, Aug. 2015, 日本腎臓学会誌, 57(6) (6), 1138 - 1138, Japanese著明な低Ca血症と低Mg血症を認め痙攣を来した常用飲酒者の1例
- 臨床体液研究会, Aug. 2015, 臨床体液, 42, 51 - 54, Japanese
- May 2015, NEPHROLOGY DIALYSIS TRANSPLANTATION, 30, EnglishSummary international conference
- May 2015, NEPHROLOGY DIALYSIS TRANSPLANTATION, 30, EnglishSummary international conference
- (一社)日本透析医学会, May 2015, 日本透析医学会雑誌, 48(Suppl.1) (Suppl.1), 508 - 508, Japanese腎移植を考慮にいれた副甲状腺機能亢進症の管理の必要性
- (一社)日本透析医学会, May 2015, 日本透析医学会雑誌, 48(Suppl.1) (Suppl.1), 887 - 887, Japanese透析導入期における心負荷と脳性ナトリウム利尿ペプチド(BNP)の関連性
- (一社)日本腎臓学会, Apr. 2015, 日本腎臓学会誌, 57(3) (3), 527 - 527, Japanese慢性腎臓病における心拍変動と臨床的背景に関する検討
- (一社)日本腎臓学会, Apr. 2015, 日本腎臓学会誌, 57(3) (3), 596 - 596, Japaneseオキサロールは糖尿病における心筋傷害進展を抑制する
- (一社)日本腎臓学会, Apr. 2015, 日本腎臓学会誌, 57(3) (3), 599 - 599, JapaneseCKD-MBDの病態生理学的機序検討のための新たなモデルラット
- 2015, 臨床体液(Web), 42低リン血症を呈したレジオネラ肺炎の2症例
- (株)日本メディカルセンター, Jan. 2015, 臨床透析, 31(1号) (1号), 72 - 73, Japanese【透析患者の悪性腫瘍の早期発見と予防】 抗がん剤投与と透析のタイミングIntroduction other
- (株)日本メディカルセンター, Oct. 2014, 腎と骨代謝, 27(4) (4), 391 - 392, Japanese糖尿病モデルラットの骨病変に対するマキサカルシトールの効果
- (NPO)日本高血圧学会, Oct. 2014, 日本高血圧学会総会プログラム・抄録集, 37回, 344 - 344, Japanese慢性腎臓病症例における血圧日内変動と腎予後の関連
- (NPO)日本高血圧学会, Oct. 2014, 日本高血圧学会総会プログラム・抄録集, 37回, 344 - 344, Japanese慢性腎臓病の進行は心拍変動性低下に関係する
- (株)日本メディカルセンター, Aug. 2014, 臨床透析, 30(9) (9), 1127 - 1133, Japanese
- (一社)日本腎臓学会, Aug. 2014, 日本腎臓学会誌, 56(6) (6), 692 - 692, Japanese妊娠により1型糖尿病性腎症の悪化をみとめ腎生検を施行した一例
- (一社)日本腎臓学会, Aug. 2014, 日本腎臓学会誌, 56(6) (6), 694 - 694, JapaneseNocardia aobensisによる肺ノカルジア症を併発した膜性腎症の一例
- (一社)日本腎臓学会, Aug. 2014, 日本腎臓学会誌, 56(6) (6), 698 - 698, Japanese低リン血症を呈したレジオネラ肺炎の2例
- (株)メディカルレビュー社, Jun. 2014, Nephrology Frontier, 13(2号) (2号), 154 - 158, Japanese[Invited]Introduction scientific journal
- May 2014, NEPHROLOGY, 19, 68 - 68, EnglishRELATIONSHIP BETWEEN LEFT VENTRICULAR HYPERTROPHY AND CORONARY ARTERY CALCIFICATION AT THE BEGINNING OF HEMODIALYSIS THERAPYSummary international conference
- May 2014, NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, 410 - 410, EnglishEFFECTS OF AST-120 ON CARDIORENAL SYNDROME IN MYOCARDIAL INFARCTION MODEL RATSSummary international conference
- (一社)日本腎臓学会, May 2014, 日本腎臓学会誌, 56(3) (3), 325 - 325, Japanese心筋梗塞モデルにおけるAST-120の心腎連関傷害進展抑制効果についての検討
- (一社)日本透析医学会, May 2014, 日本透析医学会雑誌, 47(Suppl.1) (Suppl.1), 478 - 478, Japanese重篤なAG上昇型代謝性アシドーシスに壊死性食道炎を合併した大酒家の1例
- (一社)日本透析医学会, May 2014, 日本透析医学会雑誌, 47(Suppl.1) (Suppl.1), 540 - 540, Japanese血液透析導入期における冠動脈石灰化と心臓弁石灰化の関連性について
- (一社)日本透析医学会, May 2014, 日本透析医学会雑誌, 47(Suppl.1) (Suppl.1), 812 - 812, Japanese肺炎球菌性肺炎に横紋筋融解症による急性腎障害を併発した大酒家の一例
- (一社)日本透析医学会, May 2014, 日本透析医学会雑誌, 47(Suppl.1) (Suppl.1), 892 - 892, Japanese透析導入期の骨量減少と動脈硬化の関連
- (社医)愛仁会学術部, Mar. 2014, 愛仁会医学研究誌, 45, 148 - 152, Japaneseネフローゼ症候群に進展後、厳格な降圧療法にて著明な蛋白尿改善を認めたImmunotactoid腎症の1例
- (株)医学書院, Feb. 2014, Medicina, 51(2) (2), 326 - 329, Japanese
- 日本アフェレシス学会, 2014, 日本アフェレシス学会雑誌, 33, 175 - 175, JapaneseO-46 The role of apheresis therapy for vasculitis syndrome : A single-center experience(Oral Session 11)
- (株)先端医学社, Oct. 2013, Vascular Medicine, 9(2) (2), 122 - 128, Japanese
- (一社)日本腎臓学会, Aug. 2013, 日本腎臓学会誌, 55(6) (6), 1179 - 1179, Japanese糖尿病悪化と腎機能低下を契機に診断に至ったIgG4関連疾患の一例
- (一社)日本腎臓学会, Aug. 2013, 日本腎臓学会誌, 55(6) (6), 1205 - 1205, Japanese無症候性蛋白尿からネフローゼ症候群に進展したImmunotactoid腎症の1例
- May 2013, NEPHROLOGY DIALYSIS TRANSPLANTATION, 28, 484 - 484, EnglishTHE COMPARATIVE EVALUATION CONCERNING THE START OF DIALYSIS BETWEEN ELDERLY AND YOUNGER PATIENTS IN JAPANSummary international conference
- (一社)日本透析医学会, May 2013, 日本透析医学会雑誌, 46(Suppl.1) (Suppl.1), 746 - 746, Japanese高熱と浮腫性紅斑を認めSweet病と診断された血液透析患者の一例
- (一社)日本腎臓学会, Apr. 2013, 日本腎臓学会誌, 55(3) (3), 350 - 350, JapaneseビタミンDはNrf2-Keap1経路を介して酸化ストレスを抑制し糖尿病性腎症の進展を抑制する
- (株)東京医学社, Apr. 2013, 腎と透析, 74(増刊) (増刊), 493 - 496, Japanese
- (社医)愛仁会学術部, Mar. 2013, 愛仁会医学研究誌, 44, 152 - 155, Japanese循環血液量モニタリングが腹腔-静脈シャント還流動態の評価に有効と考えられた肝硬変合併血液透析患者の1例
- (株)日本メディカルセンター, Oct. 2012, 腎と骨代謝, 25(4) (4), 342 - 342, Japaneseマキサカルシトールは酸化ストレスを抑制し、2型糖尿病における腎障害進展を抑制する
- (株)日本メディカルセンター, Oct. 2012, 腎と骨代謝, 25(4) (4), 342 - 343, Japanese2型糖尿病における早期血管病変に対するマキサカルシトールの効果
- 臨床体液研究会, Oct. 2012, 臨床体液, 39, 9 - 9, Japanese
- (NPO)日本高血圧学会, Sep. 2012, 日本高血圧学会総会プログラム・抄録集, 35回, 449 - 449, Japanese慢性腎臓病症例においては糖尿病および腎機能が血圧日内変動に関与する
- (NPO)日本高血圧学会, Sep. 2012, 日本高血圧学会総会プログラム・抄録集, 35回, 519 - 519, Japanese慢性腎臓病(CKD)における副甲状腺ホルモンと血圧の関連性について
- (一社)日本腎臓学会, Aug. 2012, 日本腎臓学会誌, 54(6) (6), 905 - 905, JapaneseMPO-ANCA関連腎炎に滲出性中耳炎による高度難聴を合併した一例
- (株)日本メディカルセンター, Jul. 2012, 腎と骨代謝, 25(3) (3), 256 - 256, Japanese胸椎に異所性副甲状腺腺腫を認めた透析患者の1例
- May 2012, NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 146 - 146, EnglishEFFECT OF VITAMIN D ON VASCULAR LESIONS AND OXIDATIVE STRESS AT EARLY STAGE OF DIABETIC NEPHROPATHYSummary international conference
- May 2012, NEPHROLOGY DIALYSIS TRANSPLANTATION, 27, 534 - 534, EnglishHYPERPARATHYROIDISM IN KIDNEY TRANSPLANT PATIENTS DISCONTINUING CINACALCET AFTER LONG-TERM HEMODIALYSISSummary international conference
- (一社)日本透析医学会, May 2012, 日本透析医学会雑誌, 45(Suppl.1) (Suppl.1), 464 - 464, Japanese慢性腎臓病患者における血管石灰化とクレメジンとの関連について
- (一社)日本透析医学会, May 2012, 日本透析医学会雑誌, 45(Suppl.1) (Suppl.1), 525 - 525, Japaneseシナカルセト投与が移植後の副甲状腺機能に及ぼす影響
- (一社)日本透析医学会, May 2012, 日本透析医学会雑誌, 45(Suppl.1) (Suppl.1), 663 - 663, JapaneseCRP陽転化透析患者のHb変動に対する網状赤血球測定の有用性
- (一社)日本腎臓学会, Apr. 2012, 日本腎臓学会誌, 54(3) (3), 303 - 303, Japanese正常血圧糸球体腎炎患者における血清ADMA濃度測定の意義
- (一社)日本腎臓学会, Apr. 2012, 日本腎臓学会誌, 54(3) (3), 325 - 325, Japanese2型糖尿病における大動脈病変に対するビタミンDの効果
- (一社)日本腎臓学会, Apr. 2012, 日本腎臓学会誌, 54(3) (3), 340 - 340, Japanese検尿異常を伴わない高齢CKD症例における腎機能低下速度に関する検討
- (有)科学評論社, Mar. 2012, 循環器内科, 71(3) (3), 285 - 288, Japanese
- (株)日本メディカルセンター, Oct. 2011, 腎と骨代謝, 24(4) (4), 319 - 319, Japanese厳格なリン管理により重度の副甲状腺機能亢進症の著明な改善を認めた妊娠透析患者の一例
- 臨床体液研究会, Oct. 2011, 臨床体液, 38, 33 - 36, Japanese
- (NPO)日本高血圧学会, Oct. 2011, 日本高血圧学会総会プログラム・抄録集, 34回, 507 - 507, Japanese慢性糸球体腎炎におけるABPM(Ambulatory blood pressure monitoring)解析と腎組織障害度との関係
- (NPO)日本高血圧学会, Oct. 2011, 日本高血圧学会総会プログラム・抄録集, 34回, 571 - 571, Japanese透析導入期の慢性腎臓病における24時間自由行動下血圧測定(ABPM)の意義
- (一社)日本腎臓学会, Aug. 2011, 日本腎臓学会誌, 53(6) (6), 805 - 805, Japanese胸椎に異所性副甲状腺腫の再発を認めた透析患者の一例
- (株)南江堂, Jun. 2011, 内科, 107(6) (6), 1139 - 1143, Japanese【内科診療における論点】腎臓 慢性糸球体腎炎に抗血小板薬・抗凝固薬は必要か?
- (一社)日本腎臓学会, May 2011, 日本腎臓学会誌, 53(3) (3), 405 - 405, Japanese糖尿病性骨病変に対するカルベジロールの効果
- (一社)日本透析医学会, May 2011, 日本透析医学会雑誌, 44(Suppl.1) (Suppl.1), 431 - 431, Japanese透析導入期における副甲状腺腫大の頻度
- (一社)日本透析医学会, May 2011, 日本透析医学会雑誌, 44(Suppl.1) (Suppl.1), 574 - 574, Japanese血漿交換が著効した産褥期重症HELLP症候群におけるADMA(Asymmetric dimethylarginine)の推移
- (株)日本メディカルセンター, Oct. 2010, 腎と骨代謝, 23(4) (4), 330 - 331, Japanese糖尿病性骨代謝異常におけるシンバスタチン投与効果
- (一社)日本腎臓学会, Aug. 2010, 日本腎臓学会誌, 52(6) (6), 826 - 826, Japanese両腎への形質細胞腫浸潤により腎機能低下を認めた一例
- (一社)日本腎臓学会, Aug. 2010, 日本腎臓学会誌, 52(6) (6), 841 - 841, JapaneseC型肝炎、移植後糖尿病を合併し、肝臓移植後に呈したネフローゼ症候群の診断に苦慮した一例
- (一社)日本透析医学会, May 2010, 日本透析医学会雑誌, 43(Suppl.1) (Suppl.1), 427 - 427, Japanese血液透析患者における冠動脈病変の特徴 VH-IVUSによる解析
- (一社)日本透析医学会, May 2010, 日本透析医学会雑誌, 43(Suppl.1) (Suppl.1), 675 - 675, Japanese透析患者におけるファブリー病に対する酵素補充療法の効果
- (一社)日本腎臓学会, May 2010, 日本腎臓学会誌, 52(3) (3), 354 - 354, JapaneseCKD患者での腹部大動脈石灰化とクレメジン内服との関連について
- (一社)日本腎臓学会, May 2010, 日本腎臓学会誌, 52(3) (3), 375 - 375, JapaneseCKD Stage 4、5におけるAST-120の心病変抑制効果の検討
- (株)日本メディカルセンター, Apr. 2010, 腎と骨代謝, 23(2) (2), 153 - 153, Japaneseシナカルセト塩酸塩の投与によりALPが上昇した1例
- (株)日本臨床社, Mar. 2010, 日本臨床, 68(増刊3 静脈・経腸栄養) (増刊3 静脈・経腸栄養), 102 - 106, Japanese【静脈・経腸栄養(第3版) 基礎・臨床研究のアップデート】代謝管理 タンパクアミノ酸代謝
- (株)ジェフコーポレーション, Mar. 2010, 静脈経腸栄養, 25(2) (2), 591 - 596, Japanese【栄養管理のピットフォール 理論と実際のはざま】脂肪乳剤投与 適応と限界は?
- Feb. 2010, Clinical Nephrology, 73(2) (2), 170 - 171Report scientific journal
- (一社)日本病態栄養学会, Dec. 2009, 日本病態栄養学会誌, 12(5) (5), 162 - 162, Japanese神戸大学栄養輸液サポートチーム(NEST)介入症例における栄養状態の改善に伴う電解質異常の変化
- (株)東京医学社, Dec. 2009, 腎と透析, 67(増刊) (増刊), 137 - 139, Japanese
- (株)ジェフコーポレーション, Sep. 2009, 静脈経腸栄養, 24(5) (5), 1045 - 1051, Japanese【必要エネルギー量の算出法と投与の実際】各種病態におけるエネルギー、基質代謝の特徴と、至適エネルギー投与量(肝障害、腎障害)
- (一社)日本腎臓学会, Aug. 2009, 日本腎臓学会誌, 51(6) (6), 776 - 776, Japaneseリツキシマブが著効した膜性腎症による難治性ネフローゼ症候群の一症例
- (一社)日本腎臓学会, Aug. 2009, 日本腎臓学会誌, 51(6) (6), 779 - 779, Japanese低尿酸血症を伴わないAcute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise(ALPE)の1例
- (一社)日本腎臓学会, Aug. 2009, 日本腎臓学会誌, 51(6) (6), 779 - 779, Japanese膜性増殖性糸球体腎炎(MPGN)治療中に腎機能悪化を認め、MPO-ANCA陽性となった若年男性の1例
- (一社)日本腎臓学会, Aug. 2009, 日本腎臓学会誌, 51(6) (6), 796 - 796, Japaneseフィブロネクチン腎症により、ネフローゼ症候群を呈した一例
- (一社)日本腎臓学会, Aug. 2009, 日本腎臓学会誌, 51(6) (6), 808 - 808, Japaneseインターフェロンβ-1bにて膜性増殖性糸球体腎炎を来たした多発性硬化症の1例
- (一社)日本腎臓学会, Aug. 2009, 日本腎臓学会誌, 51(6) (6), 819 - 819, Japanese経皮的腎動脈形成術(PTRA)が奏功した腎血管性高血圧症の2例
- 臨床体液研究会, Aug. 2009, 臨床体液, 36, 37 - 39, Japanese
- (株)メディカ出版, Jun. 2009, 透析ケア, (2009夏季増刊) (2009夏季増刊), 167 - 172, Japanese【検査結果表が読める!患者指導にいかす!透析患者の検査と検査値】血液検査 CKD-MBDガイドライン
- (一社)日本透析医学会, May 2009, 日本透析医学会雑誌, 42(Suppl.1) (Suppl.1), 538 - 538, Japanese透析患者におけるファブリー病の頻度とその特徴
- (公社)日本皮膚科学会, Mar. 2009, 日本皮膚科学会雑誌, 119(4) (4), 749 - 749, JapaneseGlomeruloid hemangiomaの組織所見より、POEMS症候群が疑われた1例
- 第28回日本医療薬学会, Nov. 2018, Japanese, 神戸, Domestic conference各種病棟で管理すべき腎機能の基準を薬剤業務支援システムで考えるPublic symposium
- 第39回日本アフェレシス学会学術大会, Oct. 2018, Japanese, 岡山, Domestic conference新鮮凍結血漿とアルブミン溶液併用による全血漿交換療法に関する検討Poster presentation
- American Society of Nephrology 2018, Oct. 2018, English, America, International conferenceThe Effects of Lanthanum Carbonate on Bone Metabolic Markers and Bone Mineral Density in Incident Hemodialysis Patients.Poster presentation
- American Society of Nephrology 2018, Oct. 2018, English, America, International conferenceProgression of abdominal aortic calcification in kidney transplantation recipients and hemodialysis patientsPoster presentation
- 第41回日本高血圧学会総会, Sep. 2018, Japanese, 旭川, Domestic conference総腸骨動脈狭窄症による急激な血圧上昇と腎機能低下を認めた腎移植患者の一例Poster presentation
- 第48回日本腎臓学会西部学術大会, Sep. 2018, Japanese, 徳島, Domestic conference自己免疫性膵炎治療中より腎機能低下を来たし治療終了後に多臓器病変へと進展したPoster presentation
- 第41回日本高血圧学会総会, Sep. 2018, Japanese, 旭川, Domestic conference血液透析患者における二次性副甲状腺機能亢進症のレニン・アルドステロン系への影響Oral presentation
- 第48回日本腎臓学会西部学術大会, Sep. 2018, Japanese, 徳島, Domestic conferenceSAPHO症候群に腎アミロイドーシスを合併した1例Poster presentation
- 第61回日本腎臓学会, Jun. 2018, Japanese, 新潟, Domestic conference慢性腎臓病における心血管疾患Public discourse
- 第61回日本腎臓学会, Jun. 2018, Japanese, 新潟, Domestic conference慢性腎臓病における心血管合併症の管理Public discourse
- 第63回日本透析医学会, Jun. 2018, Japanese, 神戸, Domestic conference兵庫県下での透析患者に対する鉄含有リン吸着薬使用に関するアンケート調査Oral presentation
- 第63回日本透析医学会, Jun. 2018, Japanese, 神戸, Domestic conference二重濾過血漿交換療法とアルブミン置換血漿交換療法の除去率に関する検討Oral presentation
- 第61回日本腎臓学会, Jun. 2018, Japanese, 新潟, Domestic conference糖尿病合併CKDモデルラットにおける血管石灰化の検討Poster presentation
- 第63回日本透析医学会, Jun. 2018, Japanese, 神戸, Domestic conference当院における血液透析患者での肺高血圧症に対する治療介入とその成果Oral presentation
- 第63回日本透析医学会, Jun. 2018, Japanese, 神戸, Domestic conference炭酸ランタンの血液透析患者骨代謝マーカーに与える影響.Oral presentation
- 第63回日本透析医学会, Jun. 2018, Japanese, 神戸, Domestic conference炭酸ランタンと炭酸カルシウムが透析導入後の弁石灰化に与える影響の比較Oral presentation
- 第61回日本腎臓学会, Jun. 2018, Japanese, 新潟, Domestic conference腎移植種類による移植後骨ミネラル代謝の特徴Poster presentation
- 55th ERA-EDTA Congress, May 2018, English, デンマーク, International conferenceTHE SIGNIFICANT RELATIONSHIP BETWEEN INTRAVENTRICULAR SEPTUM THICKNESS (IVST) AND DECLINE OF EGFR IN AA AMYLOIDOSISPoster presentation
- 55th ERA-EDTA Congress, May 2018, English, デンマーク, International conferenceINTERACTION BETWEEN PARATHYROID HORMONE AND RENIN ANGIOTENSIN ALDOSTERONE SYSTEM IN HEMODIALYSIS PATIENTSPoster presentation
- 55th ERA-EDTA Congress, May 2018, English, デンマーク, International conferenceCOMPARISON OF THE EFFECTS OF LANTHANUM CARBONATE AND CALCIUM CARBONATE ON THE PROGRESSION OF VALVULAR CALCIFICATION AFTER INITIATION OF MAINTENANCE HEMODIALYSISPoster presentation
- 第2回CKD-MBD研究会 学術集会・総会, Mar. 2018, Japanese, 日本CKD-MBD学会, Tokyo, 東京, Domestic conference血液透析患者の骨代謝に炭酸ランタンが与える影響Oral presentation
- 第51回 日本臨床腎移植学会, Feb. 2018, Japanese, 日本臨床腎移植学会, Kobe, 神戸, Domestic conference腎移植前後における心血管系合併症の管理:腎移植患者における冠動脈病変のスクリーニングPublic symposium
- ISN frontiers meeting 2018, Feb. 2018, English, SN frontiers meeting, Tokyo, 東京, Domestic conferenceCinacalcet-induced paroxysmal supraventricular tachycardia in hemodialysis patientsPoster presentation
- 第21回 日本適応医学会学術集会, Dec. 2017, Japanese, 日本適応学会, Tokyo, 東京, Domestic conference慢性腎臓病からみた心腎連関Public symposium
- American Society of Nephrology, Nov. 2017, English, アメリカ腎臓学会, Amerika, New Orleans, International conferenceRenoprotective effects of aliskiren in a non-obese type 2 diabetic model ratPoster presentation
- Congress of Asian Society of Transplantation, Nov. 2017, English, アジア移植学会, Philippines, Sebu, International conferenceOne-year impact of kidney transplantation on cardiac abnormalities in patients with chronic kidney diseasePoster presentation
- American Society of Nephrology, Nov. 2017, English, アメリカ腎臓学会, Amerika, New Orleans, International conferenceInfluence of dialysis vintage on mineral and bone disorders after kidney transplantationPoster presentation
- American Society of Nephrology, Nov. 2017, English, アメリカ腎臓学会, Amerika, New Orleans, International conferenceChange in fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model ratsPoster presentation
- American Society of Nephrology, Nov. 2017, English, アメリカ腎臓学会, Amerika, New Orleans, International conferenceChange in EXTL2, a novel factor related to vascular calcification, in hemodialysis patients.Poster presentation
- American Society of Nephrology, Nov. 2017, English, アメリカ腎臓学会, Amerika, New Orleans, International conferenceA Significance of Urine-Gravidity in Nephrotic SyndromePoster presentation
- 第38回 日本アフェレシス学会学術大会, Oct. 2017, Japanese, 日本アフェレシス学会, Chiba, 千葉, Domestic conference全身性エリテマトーデスに対する血液透析・免疫吸着療法直列法による治療経験Oral presentation
- 第47回 日本腎臓学会西部学術大会, Oct. 2017, Japanese, 日本腎臓学会, Okayama, 岡山, Domestic conferenceIgG4関連腎臓病の診断・治療後にIgG4上昇を認めない尿細管間質性腎炎を来した一例Oral presentation
- 第35回 日本骨代謝学会学術集会, Jul. 2017, Japanese, 日本骨代謝学会, Fukuoka, 福岡, Domestic conference糖尿病性骨病変に対するレニン阻害薬の効果についてOral presentation
- 第62回 日本透析医学会学術集会・総会, Jun. 2017, Japanese, 日本透析医学会, Yokohama, 横浜, Domestic conference腎・血液浄化センターの医療安全への取り組みOral presentation
- 第62回 日本透析医学会学術集会・総会, Jun. 2017, Japanese, 日本透析医学会, Yokohama, 横浜, Domestic conference血液透析患者における新たな血管石灰化関連因子であるEXTL2に関する研究Poster presentation
- 54th ERA-EDTA 2017 Congress., Jun. 2017, English, 欧州腎臓学会・欧州透析移植学会, Spain, International conferenceEFFECT OF LANTHANUM CARBONATE ON CARDIAC ABNORMALITIES IN PATIENTS NEW TO HEMODIALYSISOral presentation
- 54th ERA-EDTA 2017 Congress., Jun. 2017, English, 欧州腎臓学会・欧州透析移植学会, Spain, International conferenceDIRECT RENIN INHIBITOR ALISKIREN AMELIORATES LOW BONE TURNOVER IN DIABETIC RATOral presentation
- 第60回 日本腎臓学会学術総会, May 2017, Japanese, 日本腎臓学会, Sendai, 仙台, Domestic conference腎臓病教育入院中のeGFRの低下と腎予後の検討Poster presentation
- 第60回 日本腎臓学会学術総会, May 2017, Japanese, 日本腎臓学会, Sendai, 仙台, Domestic conference腎移植における移植1年後の心臓パラメータの変化Poster presentation
- 第60回 日本腎臓学会学術総会, May 2017, Japanese, 日本腎臓学会, Sendai, 仙台, Domestic conferenceネフローゼ症候群における血管内皮リパーゼに対するスタチンの影響Oral presentation
- 第37回 日本アフェレシス学会学術大会, Nov. 2016, Japanese, 日本アフェレシス学会, Yokohama, 横浜, Domestic conference当院における体重30kg未満の小児ABO不適合腎移植前抗体除去療法Oral presentation
- 第46回 日本腎臓学会西部学術大会, Oct. 2016, Japanese, 日本腎臓学会, Miyazaki, 宮崎, Domestic conference副甲状腺線種からの出血により深頸部縦隔血腫をきたした1例Oral presentation
- 第46回 日本腎臓学会西部学術大会, Oct. 2016, Japanese, 日本腎臓学会, Miyazaki, 宮崎, Domestic conferenceZebra-body蓄積物水晶体上皮細胞に認めたE66Q変異の1症例Oral presentation
- 第46回 日本腎臓学会西部学術大会, Oct. 2016, Japanese, 日本腎臓学会, Miyazaki, 宮崎, Domestic conferenceFanconi症候群を合併したネフローゼ症候群の一例Oral presentation
- 第39回日本高血圧学会総会, Sep. 2016, Japanese, 日本高血圧学会, Miyazaki, 宮崎, Domestic conference非顕性蛋白尿の糖尿病合併慢性腎臓病患者における血圧日内変動の特徴Oral presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conference非顕性蛋白尿を呈する糖尿病合併慢性腎臓病患者の臨床的特徴Poster presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conference先行的腎移植は移植後早期に心肥大を改善させるOral presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conference腎移植レシピエントの透析導入に関する検討Oral presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conference新規ビタミンD製剤VS-105とバリカルトシトールのCKD-MBDに対する作用の比較Oral presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conference急性冠症候群患者における血清インドキシル硫酸濃度の変化Oral presentation
- 第61回 日本透析学会学術総会, Jun. 2016, Japanese, 日本透析学会, Osaka, 大阪, Domestic conference肝硬変による難治性腹水合併症腎不全患者において、腹膣静脈シャントが体液管理に有効であった1例Oral presentation
- 第61回 日本透析学会学術総会, Jun. 2016, Japanese, 日本透析学会, Osaka, 大阪, Domestic conference維持血液透析患者における大動脈弁狭窄症手術時の臨床的特徴Oral presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conferenceHenochi-Scholein紫斑病における腎組織および臨床所見と皮膚組織所見に関する検討Poster presentation
- 第59回 日本腎臓学会学術総会, Jun. 2016, Japanese, 日本腎臓学会, Yokohama, 横浜, Domestic conferenceFanconi症候群患者における血清FGF23値Poster presentation
- 53th ERA-EDTA Congress, May 2016, English, 欧州腎臓学会, Wien, ウィーン, International conferenceSERUM FIBROBLAST GROWTH FACTOR 23 LEVELS IN PATIENTS WITH HYPOPHOSPHATEMIA DUE TO FANCONI SYNDROMEPoster presentation
- 53rd ERA-EDTA Congress, May 2016, English, 欧州腎臓学会, Wien, ウィーン, International conferenceEFFECT OF LANTHANUM CARBONATE ON CORONARY ARTERY CALCIFICATION DURING THE EARLY PERIOD AFTER THE INITIATION OF HAEMODIALYSISPoster presentation
- 第113回 日本内科学会総会・講演会, Apr. 2016, Japanese, 日本内科学会, Tokyo, 東京, Domestic conferenceネフローゼ症候群の診断鑑別における尿比重の意義[Invited]Invited oral presentation
- 第49回 日本臨床腎移植学会, Mar. 2016, Japanese, 日本臨床腎移植学会, 米子, Domestic conference神戸大学における先行的腎移植症例の検討Poster presentation
- American Society of Nephrology, Kidney Week 2015, Nov. 2015, English, アメリカ腎臓学会2016, サンディエゴ, アメリカ, International conferenceRelationship Between Circadian Rhythm of Blood Pressure and Intrarenal ArteriolosclerosisPoster presentation
- American Society of Nephrology, Kidney Week 2015, Nov. 2015, English, アメリカ腎臓学会2015, サンディエゴ, アメリカ, International conferenceEffect of a Novel Vitamin D Receptor Analog VS-105 on Chronic Kidney Disease-Mineral Bone DisorderPoster presentation
- 第45回 日本腎臓学会西部学術大会, Oct. 2015, Japanese, 日本腎臓学会, 金沢, Domestic conference著名な低Ca血症と低Mg血症を認め痙攣を来した常用飲酒者の1例Oral presentation
- 第45回 日本腎臓学会西部学術大会, Oct. 2015, Japanese, 日本腎臓学会, 金沢, Domestic conferenceレシピエントの移植後腎生検で発見されたファブリー病腎移植ドナーの1症例Oral presentation
- 60 st Annual Meeting of The Japanese Society for Dialysis Therapy, Jun. 2015, Japanese, 日本透析医学会, 横浜, Domestic conference透析導入期における心負荷と脳性ナトリウム利尿ペプチド(BNP)の関連性Poster presentation
- 60 st Annual Meeting of The Japanese Society for Dialysis Therapy, Jun. 2015, Japanese, 日本透析医学会, 横浜, Domestic conference腎移植を考慮に入れた副甲状腺機能亢進症の管理の必要性Oral presentation
- The 52nd ERA-EDTA Congress, May 2015, English, 欧州腎臓・透析移植学会議, ロンドン, イギリス, International conferenceVITAMIN D RECEPTOR ACTIVATOR MAXACALCITOL PREVENTS THE PROGRESSION OF DIABETIC CARDIOMYOPATHY INDEPENDENTLY OF RENIN ANGIOTENSIN SYSTEM INHIBITIONPoster presentation
- The 52nd ERA-EDTA Congress, May 2015, English, 欧州腎臓・透析移植学会議, ロンドン, イギリス, International conferenceBLOOD PRESSURE CHANGE IN THE TYROSINE-KINASE INHIBITORS TREATMENT OF DIALYSIS PATIENTS WITH RENAL CELL CARCINOMAPoster presentation
- 第25回 腎と妊娠研究会, Mar. 2015, Japanese, 腎と妊娠研究会, 横浜, Domestic conference1型糖尿病性腎症・顕性腎症期に妊娠、出産した一症例Public discourse
- 第48回 日本臨床腎移植学会, Feb. 2015, Japanese, 日本臨床腎移植学会, 名古屋, Domestic conference生体腎移植ドナーに発症したステロイド治療を行ったIgA腎症の一例Oral presentation
- 第26回 日本腎性骨症研究会, Feb. 2015, Japanese, 日本腎性骨症研究会, 東京都, Domestic conference腎移植を見据えたCKD-MBD管理(保存期からの透析期)Public discourse
- 第26回 日本腎性骨症研究会, Feb. 2015, Japanese, 日本腎性骨症研究会, 東京都, Domestic conferenceCKD-MBDの病態生理学的機序検討のための新たなモデルラットPublic discourse
- American Society of Nephrology, Kidney Week 2014, Nov. 2014, English, アメリカ腎臓学会, フィラデルフィア, 米国, International conferenceA newly developed chronic kidney disease–mineral bone disorder rat model.Poster presentation
- American Society of Nephrology, Kidney Week 2014, Nov. 2014, English, アメリカ腎臓学会, フィラデルフィア, 米国, International conference22-Oxacalcitriol ameliorates diabetic bone disease in diabetic model rats through antioxidative effect and increase in IGF-1.Poster presentation
- 明日から使えるPD講座, Oct. 2014, Japanese, 神戸, Domestic conference腹膜透析の基礎と療法選択Public discourse
- 第44回 日本腎臓学会西部学術大会, Oct. 2014, Japanese, 日本腎臓学会, 神戸, Domestic conference妊娠により1型糖尿病の悪化をみとめ腎生検を施行した1例Oral presentation
- 第33回 腎と骨代謝研究会, Oct. 2014, Japanese, 腎と骨代謝研究会, 東京, Domestic conference糖尿病モデルラットの骨病変に対するマキサカルシトールの効果Public discourse
- 第44回 日本腎臓学会西部学術大会, Oct. 2014, Japanese, 日本腎臓学会, 神戸, Domestic conference低リン血症を呈したレジオネラ肺炎の2例Oral presentation
- 第26回 兵庫県透析合同研究会プログラム, Oct. 2014, Japanese, 兵庫県透析合同研究会, 神戸, Domestic conferenceカリウム製剤の剤型に関する患者アンケート調査Public discourse
- 第44回 日本腎臓学会西部学術大会, Oct. 2014, Japanese, 日本腎臓学会, 神戸, Domestic conferenceNocardia acobensis による肺ノカルジア症を併発した膜性腎症の一例Oral presentation
- 第6回 腎疾患と高血圧研究会, Jul. 2014, Japanese, 腎疾患と高血圧研究会, 東京, Domestic conference心筋梗塞モデルにおける心腎傷害およびAST-120の効果についての検討Poster presentation
- 第57回日本腎臓学会学術総会, Jul. 2014, Japanese, 日本腎臓学会, 横浜, Domestic conference心筋梗塞モデルにおけるAST-120の心腎関傷害進展抑制効果についての検討Oral presentation
- 第59回 日本透析医学会学術集会, Jun. 2014, Japanese, 日本透析学会, 神戸, Domestic conference肺炎球菌性肺炎に横紋筋融解症による急性腎障害を併発した大酒家の一例Poster presentation
- 第59回 日本透析医学会学術集会, Jun. 2014, Japanese, 日本透析学会, 神戸, Domestic conference透析導入期の骨量減少と動脈硬化の関連Poster presentation
- 第59回 日本透析医学会学術集会, Jun. 2014, Japanese, 日本透析学会, Kobe, Domestic conference重篤なAG上昇型代謝性アシドーシスに壊死性食道炎を合併した大酒家の1例Oral presentation
- 第59回 日本透析医学会学術集会, Jun. 2014, Japanese, 日本透析学会, 神戸, Domestic conference血液透析導入期における冠動脈石灰化と心臓弁石灰化の関連性についてOral presentation
- ERA-EDTA Congress, Jun. 2014, English, 欧州腎臓・透析移植学会議, アムステルダム, オランダ, International conferenceEFFECTS OF AST-120 ON CARDIORENAL SYNDROME IN MYOCARDIAL INFARCTION MODEL RATSPoster presentation
- The 14th Asian Pacific Congress of Nephrology 2014, May 2014, English, アジア太平洋会議, 東京, International conferenceRelationship between leef ventricular hypertrophy and coronary artery calcification at the beginning of hemodialysis therapyOral presentation
- 第111回日本内科学会講演会 サテライトシンポジウム 医学生・研修医の内科学サミット, Apr. 2014, Japanese, 日本内科学学会, Tokyo, Domestic conference膵管内乳頭粘液性腺癌治療経過中に腎機能低下とネフローゼ症候群を呈した一例Poster presentation
- American Societyof Nephrology 2013, Nov. 2013, English, アメリカ腎臓学会, アトランタ, アメリカ, International conferenceRelationship between Coronary Artery Calcifi cation and Cardiac Valve Calcifi cation at Hemodialysis Initiation in Patients with End Stage Renal DiseasePoster presentation
- American Societyof Nephrology 2013, Nov. 2013, English, アメリカ腎臓学会, アトランタ, アメリカ, International conferenceRelationship between Circadian Variation of Blood Pressure and Renal Tissue Damage in Biopsy Proven GlomerulonephritisPoster presentation
- American Societyof Nephrology 2013, Nov. 2013, English, アメリカ腎臓学会, アトランタ, アメリカ, International conferenceMaxacarcitoriol Prevents the Progression of Cardiac Damage in Diabetes by Suppressing Oxidative StressPoster presentation
- American Societyof Nephrology 2013, Nov. 2013, English, アメリカ腎臓学会, アトランタ, アメリカ, International conferenceEffect of Standard Low-Protein Diet on Fibroblast Growth Factor 23 Levels in Patients with Early and Advanced Chronic Kidney DiseasePoster presentation
- American Societyof Nephrology 2013, Nov. 2013, English, アメリカ腎臓学会, アトランタ, アメリカ, International conferenceAnti-Oxidative Effect of β-Blocker Carvedilol on Diabetic NephropathyPoster presentation
- 第43日本腎臓学会西部学術大会, Oct. 2013, Japanese, 日本腎臓学会, 愛媛, Domestic conference無症候性蛋白尿からネフローゼ症候群に進展したImmunotactoid腎症の1例Oral presentation
- 第43日本腎臓学会西部学術大会, Oct. 2013, Japanese, 日本腎臓学会, 愛媛, Domestic conference糖尿病悪化と腎機能低下を契機に診断に至ったIgG4関連疾患に一例Oral presentation
- 第58回日本透析医学会学術集会, Jun. 2013, Japanese, 日本透析医学会, 福岡, Domestic conference高熱と浮腫性紅斑を認めSweet病と診断された血液透析患者の一例Poster presentation
- 第56回日本腎臓学会学術集会, May 2013, Japanese, 日本腎臓学会, 東京, Domestic conferenceビタミンDはNrf2-keap1経路を介して酸化ストレスを抑制し糖尿病性腎症の進展を抑制するOral presentation
- ERA-EDTA 2013, May 2013, English, 欧州腎臓・透析移植学会議, イスタンブール, トルコ, International conferenceMaxacalcitol Exerts Its Renoprotective Effects In Non-Obese Type 2 Diabetic Rats Via Suppression Of Oxidative Stress And Amelioration Of The Nrf2-Keap1 PathwayPublic symposium
- American Society of Nephrology, Nov. 2012, English, アメリカ腎臓学会, アメリカ サンディエゴ, International conferenceA Propose for Diagnostic Criteria Concerning Hemodialysis Related AmyloidosisPoster presentation
- 第42回日本腎臓学会西部学術大会, Oct. 2012, Japanese, 日本腎臓学会, 沖縄, Domestic conferenceMPO-ANCA関連腎炎に滲出性中耳炎による高度難聴を合併した一例Poster presentation
- 第36回日本高血圧学会総会, Sep. 2012, Japanese, 日本高血圧学会, 名古屋, Domestic conference慢性腎臓病(CKD)における副甲状腺ホルモンと血圧の関連性についてPoster presentation
- 第35回日本高血圧学会総会, Sep. 2012, Japanese, 日本高血圧学会, 名古屋, Domestic conference慢性腎臓病症例においては糖尿病および腎機能が血圧日内変動に関与するPoster presentation
- 6th International Symposium on ADMA, Aug. 2012, English, 第6回国際シンポジウム、ADMA, イギリス ロンドン, International conferenceEnzyme replacement therapy ameliorates coronary microvascular dysfunction and serum asymmetric dimethylarginine levels in Fabry diseaseOral presentation
- 第57回日本透析医学会, Jun. 2012, Japanese, 日本透析学会, 札幌, Domestic conference慢性腎臓病における血管石灰化とクレメジンとの関連についてOral presentation
- 第55回日本腎臓学会, Jun. 2012, Japanese, 日本腎臓学会, 横浜, Domestic conference正常血圧糸球体腎炎患者における血清ADMA濃度測定の意義Poster presentation
- 第57回日本腎臓学会, Jun. 2012, Japanese, 日本腎臓学会, 横浜, Domestic conference検尿異常を伴わない高齢CKD症例における腎機能低下速度に関する検討Poster presentation
- 第57回日本透析医学会, Jun. 2012, Japanese, 日本透析学会, 札幌, Domestic conferenceシナカルセト投与が移植後の副甲状腺機能に及ぼす影響Oral presentation
- 第12回日本NO学会学術集会, Jun. 2012, Japanese, 日本NO学会, 神戸, Domestic conferenceNO・酸化ストレスと腎臓および血管病の最前線 心腎関連におけるADMA,NO,酸化ストレス[Invited]Nominated symposium
- 第56回日本腎臓学会, Jun. 2012, Japanese, 日本腎臓学会, 横浜, Domestic conference2型糖尿病における大動脈病変に対するビタミンDの効果Poster presentation
- European Renal Association - European Dialysis and Transplant Association Congress, May 2012, English, ヨーロッパ腎協会 - ヨーロッパ透析と移植協会, フランス,パリ, International conferenceHyperparathyroidism in kidney transplant patients discontinuing cinacalcet after long-term hemodialysisPoster presentation
- European Renal Association - European Dialysis and Transplant Association Congress, May 2012, English, ヨーロッパ腎協会 - ヨーロッパ透析と移植協会, フランス,パリ, International conferenceEffect of Vitamin D on Vascular Lesions and Oxidative Stress at Early Stage of Diabetic NephropathyPublic symposium
- 第58回日本透析医学会, May 2012, Japanese, 日本透析学会, 札幌, Domestic conferenceCPR陽転化透析患者のHb変動に対する網状赤血球測定の有用性Oral presentation
- 第76回日本循環器学会総会・学術集会, Mar. 2012, Japanese, 日本循環器学会, 福岡, Domestic conferenceEffect of Enzyme Replacement Therapy on Coronary Flow Reserve and Serum Asymmetric Dimethylarginine Levels in Fabry DiseasePoster presentation
- American Society of Nephrology, Nov. 2011, English, アメリカ腎臓学会, Philadelphia, USA, International conferenceUltrastructual and Pathology in IgG4-Related Kidney Disease. American Society of NephrologyPoster presentation
- American Society of Nephrology, Nov. 2011, English, アメリカ腎臓学会, Philadelphia, USA, International conferenceRelationship between Use of AST-120 and Abdominal Aortic Calcification in Chronic Kidney Disease PatientsPoster presentation
- American Society of Nephrology, Nov. 2011, English, アメリカ腎臓学会, Philadelphia, USA, International conferenceEffect of AST-120 on Aortic and Mitral Valve Calcification in Chronic Kidney Disease Patients at Dialysis InitiationPoster presentation
- American Society of Nephrology, Nov. 2011, English, アメリカ腎臓学会, Philadelphia, USA, International conferenceClinical Characteristics of Chronic Kidney Disease Patients with Hyperkalemia due to Angiotensin II Receptor BlockerPoster presentation
- American Society of Nephrology, Nov. 2011, English, アメリカ腎臓学会, Philadelphia, USA, International conferenceClinical Characteristics and Coronary Plaque Morphology in Chronic Kidney Disease (CKD) patientsPoster presentation
- 第34回日本高血圧学会総会, Oct. 2011, Japanese, 日本高血圧学会, 宇都宮, Domestic conference慢性糸球体腎炎におけるABPM(Ambulatory blood pressure monitoring)解析と腎組織障害度との関係Oral presentation
- 第41回日本腎臓学会西部学術大会, Oct. 2011, Japanese, 日本腎臓学会, 徳島, Domestic conference胸椎に異所性副甲状腺腫の再発を認めた透析患者の一例Oral presentation
- 第56回日本透析医学会学術集会, Jun. 2011, Japanese, 日本透析医学会, 横浜, Domestic conference透析導入後における副甲状腺腫大の頻度Oral presentation
- 第54回日本腎臓病学会学術総会, Jun. 2011, Japanese, 日本腎臓病学会, 横浜, Domestic conference糖尿病骨病変に対するカルベジロールの効果Oral presentation
- 第56回日本透析医学会学術集会, Jun. 2011, Japanese, 日本透析医学会, 横浜, Domestic conference血漿交換が著効した産褥期重症HELLP症候群におけるAsymmetrical Dimethylarginine (ADMA)の推移Oral presentation
- European Renal Association - European Dialysis and Transplant Association Congress, Jun. 2011, English, ヨーロッパ腎協会 - ヨーロッパ透析と移植協会, Czech Republic, Prague, International conferenceEffect of β-blocker carvedilol on diabetic bone diseaseOral presentation
- European Renal Association - European Dialysis and Transplant Association Congress, Jun. 2011, English, ヨーロッパ腎協会 - ヨーロッパ透析と移植協会, Czech Republic, Prague, International conferenceClinical Implications of Assessing Serum Asymmetric Dimmethylarg inine (ADMA) in Normotensive Chronic Kidney Disease PatientsPoster presentation
- European Renal Association - European Dialysis and Transplant Association Congress, Jun. 2011, English, ヨーロッパ腎協会 - ヨーロッパ透析と移植協会, Czech Republic, Prague, International conferenceCharacteristics of coronary plaque morphology in patients with chronic kidney disease by VH-IVUS (Virtual Histology-Intravascular Ultrasound) analysisPoster presentation
- World Congress of Nephrology- Satellite Symposium, Apr. 2011, English, アメリカ腎臓学会, Vancouver, Canada, International conferenceEnzyme Replacement Therapy Improves Serum Asymmetric Dimethylarginine Levels and Coronary Microvascular Dysfunction in Fabry DiseasePoster presentation
- 第21回腎と妊娠研究会, Mar. 2011, Japanese, 埼玉, Domestic conference妊娠・出産後も急速進行性に腎機能が悪化し、透析導入となったANCA関連血管炎合併IgA腎症の1症例Oral presentation
- 第22回腎性骨症研究会, Feb. 2011, Japanese, 腎性骨症研究会, 東京, Domestic conference糖尿病性骨病変に対するカルベジロールの効果Oral presentation
- 第5回CKDフォーラム, Feb. 2011, English, 名古屋, Domestic conferenceEffect of AST-120 treatment on cardiac abnormalities in CKD patientsOral presentation
- 第44回日本臨床腎移植学会, Jan. 2011, Japanese, 宝塚, Domestic conference移植後尿酸値に対するカルシニューリン阻害薬の影響Oral presentation
- 第8回 高血圧UP DATE, Dec. 2010, Japanese, 東京, Domestic conference非高血圧腎疾患におけるAsymmetric diymethylarginine (ADMA)測定の意義Oral presentation
- CKD Award 2010, Nov. 2010, Japanese, 東京, Domestic conference高血圧非合併CKD患者におけるAsymmetric diymethylarginine (ADMA)と腎障害の関係およびRAS阻害薬の効果Oral presentation
- 第31回日本アフェレシス学会学術大会, Nov. 2010, Japanese, 千葉, Domestic conference劇症肝炎に対してPEに併用するHDFとAFBFの比較検討Oral presentation
- American Society of Nephrology, Nov. 2010, English, デンバー, アメリカ, International conferenceEnzyme Replacement Therapy Improves Serum Asymmetric Dimethylarginine Levels and Coronary Microvascular Dysfunction in Fabry Disease.Oral presentation
- American Society of Nephrology, Nov. 2010, English, アメリカ腎臓学会, デンバー, アメリカ, International conferenceEffect of Intravenous Iron Therapy on Serum FGF23 levels and Mineral Metabolism in ESRD patients Undergoing HemodialysisPoster presentation
- American Society of Nephrology, Nov. 2010, English, 米国腎臓学会, デンバー, アメリカ, International conferenceAssociation between renal microvascular sclerosis and asymmetric dimethylarginine in normotensive patients with primary glomerulopathyOral presentation
- 第40回日本腎臓学会西部学術大会, Oct. 2010, Japanese, 広島, Domestic conference両腎への形質細胞腫侵潤により腎機能低下に認めた一例Poster presentation
- 第42回臨床体液研究会, Oct. 2010, Japanese, 臨床体液研究会, 東京, Domestic conference低カリウム血症、高カルシウム血症を合併した慢性腎不全の1例Oral presentation
- 第40回日本腎臓学会西部学術大会, Oct. 2010, Japanese, 広島, Domestic conferenceC型肝炎、移植後糖尿病を合併し、肝臓移植後に呈したネフローゼ症候群の診断に苦慮した一例Poster presentation
- 第11回 日本腎循環器研究会, Sep. 2010, Japanese, 東京, Domestic conference血漿交換が著効した産褥期重症HELLP症候群におけるADMAOral presentation
- 第7回 腎と心血管障害研究会, Jul. 2010, Japanese, 東京, Domestic conference透析患者における心房細動の頻度とその予後についてOral presentation
- 第55回日本透析医学会学術集会, Jun. 2010, Japanese, 日本透析医学会, 神戸, Domestic conference血液透析患者における冠動脈病変の特徴~VH-IVUSによる解析~Oral presentation
- 第17回姫路ネフロロジー, Jun. 2010, Japanese, 神戸, Domestic conference肝臓移植後にネフローゼ症候群を呈した58歳男性の症例Oral presentation
- XLVII ERA-EDTA and II DGfN Congress, Jun. 2010, English, EDTA, ミュンヘン, ドイツ, International conferenceEffect of AST-120 on cardiac abnormalities in patients with chronic kidney disease (CKD) stage 4 and 5Poster presentation
- 第53回日本腎臓学会, Jun. 2010, Japanese, 日本腎臓学会, 神戸, Domestic conferenceCKD患者での腹部大動脈石灰化とクレメジン内服との関連についてPoster presentation
- 第53回日本腎臓学会学術総会, Jun. 2010, Japanese, 日本腎臓学会, 神戸, Domestic conferenceCKD Stage 4, 5におけるAST-120の心病変抑制効果の検討Poster presentation
- International Society of Nephrology, NEXUS, Apr. 2010, English, 国際腎臓学会, 京都, International conferenceOxidative and nitrosative stress are associated with the progression of diabetic nephropathy in non-obese type 2 diabetesOral presentation
- 日本アフェレシス学会
- 日本腎移植学会
- The Japanese Circulation Society
- Japanese Society of Hypertension
- THE JAPANESE SOCIETY OF INTERNAL MEDICINE
- Japanese Society for Dialysis Therapy
- JAPANESE SOCIETY OF NEPHROLOGY